
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.e22e79d5a578.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.f012d399c229.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.4455260d4345.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BDE05998BAF2D5000048A1D0EA58F2.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="1.6.0.post2+24fead6" />

<meta name="ncbi_domain" content="frontgene" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC3757297/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757297/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Frontiers in Genetics" /><meta name="citation_title" content="Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system" /><meta name="citation_author" content="Jing Jiang" /><meta name="citation_author_institution" content="1Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA" /><meta name="citation_author" content="Brooke L. Fridley" /><meta name="citation_author_institution" content="2Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA" /><meta name="citation_author" content="Qiping Feng" /><meta name="citation_author_institution" content="1Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA" /><meta name="citation_author" content="Ryan P. Abo" /><meta name="citation_author_institution" content="1Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA" /><meta name="citation_author" content="Abra Brisbin" /><meta name="citation_author_institution" content="2Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA" /><meta name="citation_author" content="Anthony Batzler" /><meta name="citation_author_institution" content="2Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA" /><meta name="citation_author" content="Gregory Jenkins" /><meta name="citation_author_institution" content="2Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA" /><meta name="citation_author" content="Pamela A. Long" /><meta name="citation_author_institution" content="1Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA" /><meta name="citation_author" content="Liewei Wang" /><meta name="citation_author_institution" content="1Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA" /><meta name="citation_publication_date" content="2013" /><meta name="citation_volume" content="4" /><meta name="citation_doi" content="10.3389/fgene.2013.00166" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3757297/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC3757297/" /><meta name="citation_pmid" content="24009623" /><meta name="DC.Title" content="Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Frontiers Media SA" /><meta name="DC.Contributor" content="Jing Jiang" /><meta name="DC.Contributor" content="Brooke L. Fridley" /><meta name="DC.Contributor" content="Qiping Feng" /><meta name="DC.Contributor" content="Ryan P. Abo" /><meta name="DC.Contributor" content="Abra Brisbin" /><meta name="DC.Contributor" content="Anthony Batzler" /><meta name="DC.Contributor" content="Gregory Jenkins" /><meta name="DC.Contributor" content="Pamela A. Long" /><meta name="DC.Contributor" content="Liewei Wang" /><meta name="DC.Date" content="2013" /><meta name="DC.Identifier" content="10.3389/fgene.2013.00166" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system" /><meta property="og:type" content="article" /><meta property="og:description" content="The mammalian target of rapamycin (mTOR) inhibitors, a set of promising potential anti-cancer agents, has shown response variability among individuals. This study aimed to identify novel biomarkers and mechanisms that might influence the response to Rapamycin ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757297/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means itï¿½s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure youï¿½re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Front%20Genet%22[journal]" class="navlink">Front Genet</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3757297
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3757297/pdf/fgene-04-00166.pdf" class="int-view">PDF (2.6M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3757297/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3757297/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3757297" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3757297%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="lW7lrJt0vRLUMprWvjnAksxCPyJcUKAtOMHIMkqOc4qRUxEcyb2bYtp0lQJmGojn">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3757297%2F&amp;text=Genome-wide%20association%20study%20for%20biomarker%20identification%20of%20Rapamycin%20and%20Everolimus%20using%20a%20lymphoblastoid%20cell%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3757297%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757297/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3757297/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/24009623/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3757297/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/24009623/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3757297/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3757297/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Front%20Genet%22[journal]" class="navlink">Front Genet</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3757297
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-frontgene.gif" alt="Logo of frontgene" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.frontiersin.org/genetics" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Front Genet.</span> 2013; 4: 166. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2013 Aug 30. </span>  <span class="doi"><span>doi:ï¿½</span><a href="//doi.org/10.3389%2Ffgene.2013.00166" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.3389/fgene.2013.00166</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3757297</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/24009623">24009623</a></div></div></div><h1 class="content-title">Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jiang%20J%5BAuthor%5D" class="affpopup" co-rid="_co_idm140263168933024" co-class="co-affbox">Jing Jiang</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Fridley%20BL%5BAuthor%5D" class="affpopup" co-rid="_co_idm140263171532800" co-class="co-affbox">Brooke L. Fridley</a>,<sup>2,</sup><sup>&#x02020;</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Feng%20Q%5BAuthor%5D" class="affpopup" co-rid="_co_idm140263192489552" co-class="co-affbox">Qiping Feng</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Abo%20RP%5BAuthor%5D" class="affpopup" co-rid="_co_idm140263192487888" co-class="co-affbox">Ryan P. Abo</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Brisbin%20A%5BAuthor%5D" class="affpopup" co-rid="_co_idm140263193687904" co-class="co-affbox">Abra Brisbin</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Batzler%20A%5BAuthor%5D" class="affpopup" co-rid="_co_idm140263194313344" co-class="co-affbox">Anthony Batzler</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jenkins%20G%5BAuthor%5D" class="affpopup" co-rid="_co_idm140263194311232" co-class="co-affbox">Gregory Jenkins</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Long%20PA%5BAuthor%5D" class="affpopup" co-rid="_co_idm140263194883040" co-class="co-affbox">Pamela A. Long</a>,<sup>1</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wang%20L%5BAuthor%5D" class="affpopup" co-rid="_co_idm140263188392016" co-class="co-affbox">Liewei Wang</a><sup>1,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140263168933024"><h3 class="no_margin">Jing Jiang</h3><p><sup>1</sup>Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jiang%20J%5BAuthor%5D">Jing Jiang</a></div></div><div id="_co_idm140263171532800"><h3 class="no_margin">Brooke L. Fridley</h3><p><sup>2</sup>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Fridley%20BL%5BAuthor%5D">Brooke L. Fridley</a></div></div><div id="_co_idm140263192489552"><h3 class="no_margin">Qiping Feng</h3><p><sup>1</sup>Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Feng%20Q%5BAuthor%5D">Qiping Feng</a></div></div><div id="_co_idm140263192487888"><h3 class="no_margin">Ryan P. Abo</h3><p><sup>1</sup>Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Abo%20RP%5BAuthor%5D">Ryan P. Abo</a></div></div><div id="_co_idm140263193687904"><h3 class="no_margin">Abra Brisbin</h3><p><sup>2</sup>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Brisbin%20A%5BAuthor%5D">Abra Brisbin</a></div></div><div id="_co_idm140263194313344"><h3 class="no_margin">Anthony Batzler</h3><p><sup>2</sup>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Batzler%20A%5BAuthor%5D">Anthony Batzler</a></div></div><div id="_co_idm140263194311232"><h3 class="no_margin">Gregory Jenkins</h3><p><sup>2</sup>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jenkins%20G%5BAuthor%5D">Gregory Jenkins</a></div></div><div id="_co_idm140263194883040"><h3 class="no_margin">Pamela A. Long</h3><p><sup>1</sup>Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Long%20PA%5BAuthor%5D">Pamela A. Long</a></div></div><div id="_co_idm140263188392016"><h3 class="no_margin">Liewei Wang</h3><p><sup>1</sup>Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wang%20L%5BAuthor%5D">Liewei Wang</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140263193630784_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140263193630784_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140263193630784_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140263193630784_ai" style="display:none"><div class="fm-affl" id="aff1"><sup>1</sup>Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA</div><div class="fm-affl" id="aff2"><sup>2</sup>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA</div><div id="fn-a.p.b.g.a">Edited by: Amit V. Pandey, University of Bern, Switzerland</div><div id="fn-a.p.b.g.b">Reviewed by: Wanqing Liu, Purdue University, USA; Mahendra P. Singh, CSIR-Indian Institute of Toxicology Research, India</div><div id="fn001">*Correspondence: Liewei Wang, Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA e-mail: <a href="mailto:dev@null" data-email="ude.oyam@ieweil.gnaw" class="oemail">ude.oyam@ieweil.gnaw</a></div><div id="fn002">This article was submitted to Pharmacogenetics and Pharmacogenomics, a section of the journal Frontiers in Genetics.</div><div id="fn003">&#x02020;Present address: Brooke L. Fridley, Department of Biostatistics, University of Kansas Medical Center, Kansas City, USA</div></div><div class="fm-article-notes hide half_rhythm" id="idm140263193630784_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2013 Jul 2; Accepted 2013 Aug 10.</div></div><div class="permissions half_rhythm hide" id="idm140263193630784_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2013 Jiang, Fridley, Feng, Abo, Brisbin, Batzler, Jenkins, Long and Wang.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div><a href="/pmc/articles/PMC3757297/bin/DataSheet1.PDF" data-ga-action="click_feat_suppl">DataSheet1.PDF</a><span style="color:gray"> (275K)</span></div><div class="small guid">GUID:ï¿½BB2FEB26-88C4-4E76-AD45-FA4CFED2F4F5</div></div></dd></dl></div><div id="abstract-a.p.b.n" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.p.b.ntitle">Abstract</h2><!--article-meta--><div><p class="p p-first-last">The mammalian target of rapamycin (mTOR) inhibitors, a set of promising potential anti-cancer agents, has shown response variability among individuals. This study aimed to identify novel biomarkers and mechanisms that might influence the response to Rapamycin and Everolimus. Genome-wide association (GWA) analyses involving single nucleotide polymorphisms (SNPs), mRNA, and microRNAs microarray data were assessed for association with area under the cytotoxicity dose response curve (AUC) of two mTOR inhibitors in 272 human lymphoblastoid cell lines (LCLs). Integrated analysis among SNPs, expression data, microRNA data and AUC values were also performed to help select candidate genes for further functional characterization. Functional validation of candidate genes using siRNA screening in multiple cell lines followed by MTS assays for the two mTOR inhibitors were performed. We found that 16 expression probe sets (genes) that overlapped between the two drugs were associated with AUC values of two mTOR inhibitors. One hundred and twenty seven and one hundred SNPs had <em>P</em> &#x0003c; 10<sup>&#x02212;4</sup>, while 8 and 10 SNPs had <em>P</em> &#x0003c; 10<sup>&#x02212;5</sup> with Rapamycin and Everolimus AUC, respectively. Functional studies indicated that 13 genes significantly altered cell sensitivity to either one or both drugs in at least one cell line. Additionally, one microRNA, miR-10a, was significantly associated with AUC values for both drugs and was shown to repress expression of genes that were associated with AUC and desensitize cells to both drugs. In summary, this study identified genes and a microRNA that might contribute to response to mTOR inhibitors.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">mTOR, pharmacogenomics, genome-wide association, Rapamycin, Everolimus</span></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p class="p p-first">The mammalian target of rapamycin (mTOR), a kinase acting downstream of the PI3K/AKT signaling pathway, is a critical regulator of basic cellular functions and plays an important role in tumor progression. Activated mTOR as a response to nutritional status promotes cell growth, proliferation, motility, and metabolism (Guertin and Sabatini, <a href="#B18" rid="B18" class=" bibr popnode">2005</a>; Petroulakis et al., <a href="#B41" rid="B41" class=" bibr popnode">2006</a>) through the regulation of a wide range of cellular activities, including translation, transcription, mRNA turnover, protein stability, actin cytoskeletal organization, and autophagy (Jacinto and Hall, <a href="#B23" rid="B23" class=" bibr popnode">2003</a>; Inoki et al., <a href="#B22" rid="B22" class=" bibr popnode">2005</a>). The best characterized function of mTOR in mammalian cells is regulation of protein translation through key downstream effectors of mTOR complex 1 (TORC1), the ribosomal S6 kinase (S6K) and eukaryote initiation factor 4E binding protein (4EBP1). S6K is the major ribosomal protein S6 kinase in mammalian cells. Phosphorylation of the S6 protein by S6K selectively increases the translation of mRNAs containing a tract of pyrimidines motif, which encode ribosomal proteins and other translation regulators, thereby enhancing the overall translation capacity of the cells (Meyuhas, <a href="#B32" rid="B32" class=" bibr popnode">2000</a>; Inoki et al., <a href="#B22" rid="B22" class=" bibr popnode">2005</a>). 4EBP1 acts as a translational repressor by binding and inhibiting the eukaryotic translation initiation factor 4E (elF4E), which recognizes the 5&#x02032;-end cap of eukaryotic mRNAs (Cho et al., <a href="#B8" rid="B8" class=" bibr popnode">2005</a>; Richter and Sonenberg, <a href="#B44" rid="B44" class=" bibr popnode">2005</a>). Phosphorylation of 4EBP1 by mTOR results in the dissociation of 4EBP1 from elF4E, thereby relieving the inhibition of elF4E-dependent translation initiation by 4EBP1.</p><p>Since aberrant activity of the PI3K/AKT/mTOR pathway is commonly observed in cancer, mTOR inhibitors (e.g., Everolimus, Deferolimus, and Temsirolimus) have emerged as promising therapeutic agents for the treatment of a variety types of cancer, including renal-cell carcinoma, breast carcinoma, non-small-cell lung carcinoma, endometrial carcinoma, glioblastoma, and mantle cell lymphoma (Chapman and Perry, <a href="#B7" rid="B7" class=" bibr popnode">2004</a>; Rowinsky, <a href="#B45" rid="B45" class=" bibr popnode">2004</a>; Vignot et al., <a href="#B51" rid="B51" class=" bibr popnode">2005</a>; Hartford and Ratain, <a href="#B20" rid="B20" class=" bibr popnode">2007</a>). However, mTOR inhibitors have severe adverse effects such as nephrotoxicity and potential immune suppression (i.e., skin reactions, mucositis, and myelosuppression) (Rowinsky, <a href="#B45" rid="B45" class=" bibr popnode">2004</a>; Guertin and Sabatini, <a href="#B18" rid="B18" class=" bibr popnode">2005</a>; Vignot et al., <a href="#B51" rid="B51" class=" bibr popnode">2005</a>). Many factors contribute to mTOR drug response, with genetic variation being one major factor. To maximize the efficacy and safety of mTOR inhibitors, there is a critical need to identify genetic biomarkers for response and to elucidate specific mechanisms by which these biomarkers might be involved in response to mTOR inhibitors.</p><p class="p p-last">In the present study, we aimed to identify novel pharmacogenomic candidates that might contribute to variation in response to two mTOR inhibitors, Rapamycin and Everolimus, using a cell line system consisting of 300 human lymphoblastoid cell lines (LCLs) from three ethnic groups. In addition to cytotoxicity represented by the dose response curves (AUCs) for the two mTOR inhibitors, we have also obtained extensive genomic information for these LCLs, including approximately 1.3 million SNPs, 54,613 mRNA expression probe sets and 228 microRNA probe sets. This model system has previously been utilized successfully to identify genetic biomarkers associated with drug response for a variety of anti-cancer agents (Li et al., <a href="#B27" rid="B27" class=" bibr popnode">2008</a>, <a href="#B28" rid="B28" class=" bibr popnode">2009</a>; Pei et al., <a href="#B40" rid="B40" class=" bibr popnode">2009</a>; Niu et al., <a href="#B36" rid="B36" class=" bibr popnode">2010</a>), as well as to interpret GWAS signals identified during clinical pharmacogenomic studies of aromatase inhibitor induced musculoskeletal adverse events (Ingle et al., <a href="#B21" rid="B21" class=" bibr popnode">2010</a>). In this study, we performed genome-wide association (GWA) analyses among SNPs, mRNA expression, microRNA expression, and cytotoxicity phenotypes, as measured by AUC values, for two mTOR inhibitors to identify candidate genes or microRNAs that might contribute to variation in response to mTOR inhibitors. We subsequently validated 13 of these candidate genes and one microRNA using siRNA screening followed by MTS and colony formation assays.</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Materials and methods</h2><div id="sec-a.q.b.b" class="sec sec-first"><h3 id="sec-a.q.b.btitle">Cell lines</h3><p class="p p-first-last">300 EVB-transformed LCLs from healthy subjects (sample sets HD100CAU, HD100AA, HD100HCA) were obtained from the Coriell Cell Repository (Camden, NJ, USA), as reported previously (Li et al., <a href="#B27" rid="B27" class=" bibr popnode">2008</a>; Niu et al., <a href="#B36" rid="B36" class=" bibr popnode">2010</a>). All of these samples had been anonymized by the National Institute of General Medical Sciences (NIGMS) before deposit, and all subjects had provided written consent for the use for their DNA and cells for experimental purpose. Two hundred and seventy two LCLs from 87 Caucasian&#x02013;American (CA), 91 African&#x02013;American (AA) and 94 Han Chinese&#x02013;American (HCA) subjects were included in this study. Human diploid fibroblast IMR-90 cell and human renal carcinoma Caki2 cells were provided by Dr. Andrew H. Limper, and Dr. Haidong Dong, respectively, at the Mayo Clinic. The human glioma U87 cell line was purchased from ATCC (no. HTB-14). LCLs were cultured in RPMI 1640 media (Cellgro, VA) supplemented with 15% FBS (Atlanta Biologicals, GA, USA). Caki2 cells were cultured in RPMI 1640 containing 10% FBS. Both the IMR90 and U87 cell lines were grown in DMEM media (GIBCO, Carlsbad, CA, USA) with 10% FBS.</p></div><div id="sec-a.q.b.c" class="sec"><h3 id="sec-a.q.b.ctitle">Transient transfection and RNA interference</h3><p class="p p-first-last">SiRNA duplex for candidate genes and negative control, as well as miR-10a inhibitor, microRNA inhibitor negative control, miR-10a mimic and microRNA mimic negative control were all purchased from Dharmacon Inc. (Lafayette, CO, USA). Cells were reversely transfected with 30 nM of siRNA or microRNA mimic/inhibitors with Lipofectamin&#x02122; RNAiMax transfection reagent (Invitrogen, Carlsbad, CA, USA).</p></div><div id="sec-a.q.b.d" class="sec"><h3 id="sec-a.q.b.dtitle">Drug treatment</h3><p class="p p-first-last">The mTOR inhibitors, Rapamycin and Everolimus, were purchased from Sigma-Aldrich (St. Louis, MO). Lymphoblastoid cells were seeded in 96 well plates 2 h before drug treatment, whereas IMR90, U87, and Caki2 cells were plated 24 h before drug treatment to allow the cells to adhere. Rapamycin and Everolimus were added to the wells at 8 concentrations ranging from 10<sup>&#x02212;7</sup> nM to 1 &#x003bc;M for 72 h before cytotoxicity analysis. For colony formation assay, cells were treated with 0.1, 0.25, 0.5, 0.75, and 1 nM concentration of the two drugs.</p></div><div id="sec-a.q.b.e" class="sec"><h3 id="sec-a.q.b.etitle">Cytotoxicity assay</h3><p class="p p-first-last">Cytotoxicity assays with all cell lines were performed with the CellTiter-96&#x000ae; AQ<sub>ueous</sub> MTS Proliferation Assay (Promega Corporation, Madison, WI, USA) in 96 well plates. LCLs were seeded at a density of 5 &#x000d7; 10<sup>5</sup>cells/ml (100 &#x003bc;l/well), and IMR90, U87 and Caki2 cells were plated at 2.5 &#x000d7; 10<sup>4</sup> cells/ml (100 &#x003bc;l/well). Cytotoxicity was measured by adding 20 &#x003bc; l MTS reagent to each well 72 h after drug treatment. Cytotoxicity for human tumor cell lines and fibroblasts were performed using the same procedure except that in this case, cells were incubated overnight before drug treatment.</p></div><div id="sec-a.q.b.f" class="sec"><h3 id="sec-a.q.b.ftitle">Colony formation assay</h3><p class="p p-first-last">Caki2 cells were seeded in 6 well plates. Twenty-four hours later, drugs were added and the cells were incubated for an additional 12 days. Colonies were then fixed with methanol, stained with crystal violet (Bio-Rad Laboratories, Inc. Hercules, CA, USA) and counted visually.</p></div><div id="sec-a.q.b.g" class="sec"><h3 id="sec-a.q.b.gtitle">Real-time quantitative reverse transcription-PCR (qRT-PCR)</h3><p class="p p-first-last">mRNA was extracted by the use of ZR RNA MiniPrep&#x02122; kit (Zymo Research, Irvine, CA, USA), followed by one-step qRT-PCR performed with the SYBR&#x000ae; Green PCR Master Mix kit (Applied Biosystems Inc., Foster City, CA, USA). microRNA was extracted with the miRNeasy Mini Kit (QIAGEN), reverse transcribed with miScript Reverse Transcription Kit (QIAGEN) and detected by the use of the miScript SYBR Green PCR Kit (QIAGEN). Specific primers for mRNA and microRNA amplifications were purchased from QIAGEN.</p></div><div id="sec-a.q.b.h" class="sec"><h3 id="sec-a.q.b.htitle">Genome-wide SNP and expression data</h3><p class="p p-first-last">The genotyping and expression array data were obtained for all 272 LCLs and were quality controlled as previously described (Li et al., <a href="#B27" rid="B27" class=" bibr popnode">2008</a>; Niu et al., <a href="#B36" rid="B36" class=" bibr popnode">2010</a>). These data are publically available from the NCBI Gene Expression Omnibus (<a href="http://www.ncbi.nlm.nih.gov/geo" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/geo</a>) under SuperSeries accession numbers <a id="__tag_330725225" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE24277" ref="/geo/query/acc.cgi?acc=GSE24277"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE24277","term_id":"24277"}}</span>GSE24277</a> and <a id="__tag_330725226" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE23120" ref="/geo/query/acc.cgi?acc=GSE23120"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE23120","term_id":"23120"}}</span>GSE23120</a>. Briefly, DNA for all of the LCLs were genotyped in the Genotype Shared Resource (GSR) at the Mayo Clinic, using Illumina HumanHap 550K and 510S BeadChips containing 561,298 and 493,750 SNPs, respectively. In addition, we also obtained publically available Affymetrix SNP Array 6.0 Chip SNP data involving 643,600 SNPs for these cells. SNPs with call rate less than 95%, minor allele frequency (MAF) less than 0.05 or Hardy&#x02013;Weinberg Equilibrium (HWE) <em>p</em>-values less than 0.001 were removed. Overall, 1,348,798 SNPs passed quality control. Total RNA was extracted using RNeasy Mini kits (QIAGEN Inc., Valencia, CA, USA). mRNAs were assayed after hybridization to Affymetrix U133 Plus 2.0 GeneChips (54,613 probe sets), as previously described (Li et al., <a href="#B27" rid="B27" class=" bibr popnode">2008</a>; Niu et al., <a href="#B36" rid="B36" class=" bibr popnode">2010</a>).</p></div><div id="sec-a.q.b.i" class="sec"><h3 id="sec-a.q.b.ititle">microRNA expression data</h3><p class="p p-first-last">MicroRNA was extracted from each of the cell lines using the mirVana&#x02122; microRNA isolation kit (Ambion, Austin, TX, USA). microRNA quality was tested using an Agilent Bioanalyzer, followed by microRNA BeadArray (Illumina, Inc., San Diego, CA, USA), as described previously (Cunningham et al., <a href="#B12" rid="B12" class=" bibr popnode">2009</a>). Briefly, total RNA were polyadenylated and then reversely transcribed into cDNA using a biotinylated oligo-dT primer with a universal PCR sequence at its 5&#x02032;-end. This was followed by annealing of the microRNA-specific oligonucleotide (MSO) pool. Common primers were used to amplify the cDNA templates. The single-stranded PCR products were hybridized to the Sentrix Array Matrix (SAM), where the fluorescently labeled strand binds to the bead on the array containing the complementary address sequences. The SAMs were imaged using an Illumina's BeadArray Reader to measure fluorescence intensity, and were analyzed by using Illumina's BeadStudio version 3.1.1. After removing probes with =80% missing (using a <em>p</em>-value detection threshold of 0.01) and individual cell lines with =50% missing, 453 probes out of the initial 733 probe sets for 282 individual samples remained. Finally, probes with SD of expression levels among and of the cell lines &#x0003c; 0.40 were removed, leaving 228 probes for analysis.</p></div><div id="sec-a.q.b.j" class="sec sec-last"><h3 id="sec-a.q.b.jtitle">Statistical analysis</h3><p class="p p-first-last">A detailed description of analysis methods for assessing the association of cytotoxicity phenotypes with SNP and/or mRNA expression data using these LCLs has been described elsewhere (Li et al., <a href="#B27" rid="B27" class=" bibr popnode">2008</a>, <a href="#B28" rid="B28" class=" bibr popnode">2009</a>; Niu et al., <a href="#B36" rid="B36" class=" bibr popnode">2010</a>). Cytotoxicity phenotypes were determined by the best fitting curve using the R package &#x0201c;drc&#x0201d; (dose response curve) (<a href="http://cran.r-project.org/web/packages/drc.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://cran.r-project.org/web/packages/drc.pdf</a>) based on a logistic model, either 4 parameter logistic, 4 parameter logistic with top = 100%, or 4 parameter logistic with bottom = 0%. The AUC phenotype was determined using the best fitting curve by numerically determining the area under the curve from dose 10<sup>&#x02212;7</sup> nM to 1 &#x003bc;M. Since the LCLs represent variation from different sexes and races, the AUC phenotype was Van der Waerden transformed, adjusted for sex, race, and population stratification as previously described (Li et al., <a href="#B27" rid="B27" class=" bibr popnode">2008</a>; Niu et al., <a href="#B36" rid="B36" class=" bibr popnode">2010</a>), and standardized for association analysis. SNP data was assessed by population stratigication using the method described by Price et al. (<a href="#B42" rid="B42" class=" bibr popnode">2006</a>). In addition, expression array data was adjusted on standardized residuals for gender, race and batch after Log2 transformation and GCRMA normalization (Ballman et al., <a href="#B3" rid="B3" class=" bibr popnode">2004</a>; Wu et al., <a href="#B53" rid="B53" class=" bibr popnode">2004</a>). MicroRNA probes were transformed using a van der Waerden transformation followed by adjusting for all the factors as expression data. Pearson correlations were calculated to quantify the association between adjusted SNPs and AUC values. Similar correlation analyses were also performed between AUC values with normalized and adjusted mRNA expression microRNA data. False discovery rate <em>Q</em>-values (Storey, <a href="#B49" rid="B49" class=" bibr popnode">2003</a>, <a href="#B48" rid="B48" class=" bibr popnode">2002</a>) were computed for each test. For siRNA and miR-10a transfection experiments, group mean values for AUC and gene expression were compared by using Student's <em>t</em>-test.</p></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Results</h2><div id="sec-a.q.c.b" class="sec sec-first"><h3 id="sec-a.q.c.btitle">Cytotoxicity of rapamycin and everolimus in lymphoblastoid cell lines</h3><p class="p p-first">Cytotoxicity studies were performed to determine the variation of drug response (sensitivity or resistance) to Rapamycin and Everolimus among 272 individual LCLs from three ethnic groups. Representative cytotoxicity data for Rapamycin and Everolimus demonstrated the variation in drug response among individual cell lines (refer to Figures <a href="/pmc/articles/PMC3757297/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>1A,B</span></a>). AUC values for each cell line were calculated to capture the entire cytotoxicity curve. The frequency distribution of AUC values for both drugs were shown in Figures <a href="/pmc/articles/PMC3757297/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>1C,D</span></a>. The mean AUC values &#x000b1; standard error (SE) for Rapamycin and Everolimus were 9.2 &#x000b1; 0.15 and 9.6 &#x000b1; 0.14, respectively. The AUC values for the two mTOR inhibitors were highly correlated (<em>R</em> = 0.833 and <em>p</em> = 1.78e&#x02212;70). Neither race (<em>P</em> = 0.458, Rapamycin; <em>P</em> = 0.096, Everolimus) nor gender (<em>P</em> = 0.252, Rapamycin; <em>P</em> = 0.292, Everolimus) was significantly associated with Rapamycin or Everolimus AUC values (Supplementary Figure <a href="#SM1" rid="SM1" class=" supplementary-material">S1</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3757297/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140263192735728"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3757297_fgene-04-00166-g0001.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fgene-04-00166-g0001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3757297/bin/fgene-04-00166-g0001.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140263192735728"><a target="object" rel="noopener" href="/pmc/articles/PMC3757297/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3757297/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p><strong>Cytotoxicity of Rapamycin and Everolimus</strong>. Representative cytotoxicity dose response curves for Rapamycin <strong>(A)</strong> and Everolimus <strong>(B)</strong>. Two cell lines from each of the three ethnic groups studied (AA, African American, CA, Caucasian American and HC, Han Chinese American) were selected to illustrate a range of Rapamycin and Everolimus cytotoxicity. The x-axis indicates the log transformed dosage (nM) and the y-axis indicates the cell viability normalized to control (without drug treatment). Symbols represent individual cell line from different ethnic groups. Histograms of frequency distributions of AUC values for Rapamycin <strong>(C)</strong> and Everolimus <strong>(D)</strong> for 272 lymphoblastoid cell lines.</p></div></div></div></div><div id="sec-a.q.c.c" class="sec sec-last"><h3 id="sec-a.q.c.ctitle">Genome-wide associations for candidate gene identification</h3><div id="sec-a.q.c.c.b" class="sec sec-first"><p></p><h4 id="sec-a.q.c.c.btitle" class="inline">mRNA expression vs. cytotoxicity </h4><p class="p p-first">We first identified candidate genes with expression levels that were strongly correlated with cytotoxicity AUCs for Rapamycin and Everolimus, respectively (refer to Figures <a href="/pmc/articles/PMC3757297/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>2A,B</span></a>). Only probe set 229939_at (<em>FLJ35220)</em> for Rapamycin and 229419_at (<em>FBXW7</em>) for Everolimus was genome-wide significant after Bonferroni correction (<em>P</em> = 0.006 and 0.02, respectively). Forty-nine probe sets (for 48 genes) and 56 probe sets (for 55 genes) were found to be associated with Rapamycin and Everolimus AUCs with <em>P</em> = 10<sup>&#x02212;4</sup> (Supplementary Tables <a href="#SM1" rid="SM1" class=" supplementary-material">S1</a>, <a href="#SM1" rid="SM1" class=" supplementary-material">S2</a>). Among these probe sets, 16 probe sets (genes) overlapped between the two drugs. Additionally, 3 and 12 genes were highly associated with both Rapamycin and Everolimus AUCs with <em>P</em> &#x0003c; 10<sup>&#x02212;5</sup>, respectively. The most significant probe set for an annotated gene was <em>PBX3</em> (<em>P</em> = 3.45 &#x000d7; 10<sup>&#x02212;6</sup>) for Rapamycin and <em>FBXW7</em> for (<em>P</em> = 3.88 &#x000d7; 10<sup>&#x02212;7</sup>) for Everolimus. Two genes were found to have 2 probe sets associated with AUC values for each of the drugs (<em>P</em> &#x0003c; 10<sup>&#x02212;4</sup>): <em>IQSEC1</em> (203906_at, <em>P</em> = 3.70 &#x000d7; 10<sup>&#x02212;5</sup>; 203907_s_at, <em>P</em> = 5.82 &#x000d7; 10<sup>&#x02212;5</sup>) and <em>ZNF765</em> (1558942_at, <em>P</em> = 6.84 &#x000d7; 10<sup>&#x02212;5</sup>; 1558943_x_at, <em>P</em> = 3.49 &#x000d7; 10<sup>&#x02212;5</sup>) for Rapamycin; and <em>FBXW7</em> (229419_at, <em>P</em> = 3.88 &#x000d7; 10<sup>&#x02212;7</sup>; 222729_at, <em>P</em> = 4.78 &#x000d7; 10<sup>&#x02212;5</sup>) and <em>GIMAP1</em> (1552316_a_at, <em>P</em> = 5.48 &#x000d7; 10<sup>&#x02212;6</sup>; 1552315_at, <em>P</em> = 9.63 &#x000d7; 10<sup>&#x02212;5</sup>) for Everolimus.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3757297/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140263194489488"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3757297_fgene-04-00166-g0002.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fgene-04-00166-g0002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3757297/bin/fgene-04-00166-g0002.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140263194489488"><a target="object" rel="noopener" href="/pmc/articles/PMC3757297/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3757297/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p><strong>Genome-wide association of mRNA expression and SNPs with Rapamycin and Everolimus cytotoxicity</strong>. Association of basal gene expression with AUC values for Rapamycin <strong>(A)</strong> and Everolimus <strong>(B)</strong>. Genome-wide association of SNPs with AUC values for Rapamycin <strong>(C)</strong> and Everolimus <strong>(D)</strong>. The x-axis represents chromosomal locations of gene probe sets or SNPs, and the y-axis represents the &#x02212;log<sub>10</sub>(<em>P</em>-value) for the association of individual expression array probe sets or SNPs with AUC values. A <em>P</em>-value of 10<sup>&#x02212;4</sup> is represented by a horizontal line.</p></div></div></div><p class="p">For the functional validation, we included the 16 overlapping genes for both drugs with <em>P</em> &#x0003c; 10<sup>&#x02212;4</sup>, genes with <em>P</em> &#x0003c; 10<sup>&#x02212;5</sup> for Rapamycin or Everolimus, as well as the 4 genes that had 2 probe sets associated with AUC values with <em>P</em> &#x0003c; 10<sup>&#x02212;4</sup> for each drug. Among those genes, we then removed genes with low expression levels in the LCLs (&#x0003c;50 after GCRMA normalization). Therefore, 13 genes were selected for inclusion in the subsequent functional validation studies (refer to Table <a href="/pmc/articles/PMC3757297/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1A</span></span><span>1A</span></a> and Figure <a href="/pmc/articles/PMC3757297/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure3</span></span><span>3</span></a>).</p><!--table ft1--><!--table-wrap-group mode="anchored" t5--><div class="table-wrap-group anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p><strong>Candidate genes selected for siRNA screening based on GWA analysis</strong>.</p></div><!--table-wrap mode="anchored" t6--><div class="table-wrap anchored whole_rhythm" id="d35e680"><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" valign="top" colspan="9" rowspan="1"><strong>A. mRNA Exp vs. AUC (Panel 1)</strong></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"><strong>Gene symbol</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Chr</strong>.</th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Probe id</strong></th><th align="center" valign="top" colspan="3" rowspan="1"><strong>Rapamycin</strong></th><th align="center" valign="top" colspan="3" rowspan="1"><strong>Everolimus</strong></th></tr><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>P</em></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>R</em><sup>*</sup></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>Q</em><sup>**</sup></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>P</em></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>R</em><sup>*</sup></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>Q</em><sup>**</sup></strong></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">BTG2</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">201236_s_at</td><td align="left" valign="top" rowspan="1" colspan="1">6.97E-06</td><td align="left" valign="top" rowspan="1" colspan="1">0.27</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td><td align="left" valign="top" rowspan="1" colspan="1">1.56E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.26</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FBXW7</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">229419_at</td><td align="left" valign="top" rowspan="1" colspan="1">1.95E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.26</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td><td align="left" valign="top" rowspan="1" colspan="1">3.88E-07</td><td align="left" valign="top" rowspan="1" colspan="1">0.30</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">STAU1</td><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">207320_x_at</td><td align="left" valign="top" rowspan="1" colspan="1">2.48E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.25</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td><td align="left" valign="top" rowspan="1" colspan="1">3.04E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.25</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GIMAP7</td><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">228071_at</td><td align="left" valign="top" rowspan="1" colspan="1">3.91E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.25</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td><td align="left" valign="top" rowspan="1" colspan="1">3.80E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.25</td><td align="left" valign="top" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PHLDA1</td><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">217996_at</td><td align="left" valign="top" rowspan="1" colspan="1">4.48E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.24</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td><td align="left" valign="top" rowspan="1" colspan="1">3.86E-06</td><td align="left" valign="top" rowspan="1" colspan="1">0.28</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NDUFAF2</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">228355_s_at</td><td align="left" valign="top" rowspan="1" colspan="1">4.75E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.24</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td><td align="left" valign="top" rowspan="1" colspan="1">2.17E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.25</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SLC39A9</td><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">222445_at</td><td align="left" valign="top" rowspan="1" colspan="1">6.79E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.23</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td><td align="left" valign="top" rowspan="1" colspan="1">1.48E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.26</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GIMAP1</td><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">1552316_a_at</td><td align="left" valign="top" rowspan="1" colspan="1">8.16E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.24</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td><td align="left" valign="top" rowspan="1" colspan="1">5.48E-06</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.27</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ECOP</td><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">208091_s_at</td><td align="left" valign="top" rowspan="1" colspan="1">9.42E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.23</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td><td align="left" valign="top" rowspan="1" colspan="1">1.05E-06</td><td align="left" valign="top" rowspan="1" colspan="1">0.29</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MGLL</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">225102_at</td><td align="left" valign="top" rowspan="1" colspan="1">1.04E-04</td><td align="left" valign="top" rowspan="1" colspan="1">0.23</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td><td align="left" valign="top" rowspan="1" colspan="1">3.94E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.25</td><td align="left" valign="top" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PBX3</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">204082_at</td><td align="left" valign="top" rowspan="1" colspan="1">3.45E-06</td><td align="left" valign="top" rowspan="1" colspan="1">0.28</td><td align="left" valign="top" rowspan="1" colspan="1">0.08</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ZNF765</td><td align="left" valign="top" rowspan="1" colspan="1">19</td><td align="left" valign="top" rowspan="1" colspan="1">1558942_at</td><td align="left" valign="top" rowspan="1" colspan="1">6.84E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.24</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">1558943_x_at</td><td align="left" valign="top" rowspan="1" colspan="1">3.49E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.25</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GIMAP6</td><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">229367_s_at</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">9.79E-06</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.2646</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140263188690016"><a target="object" rel="noopener" href="/pmc/articles/PMC3757297/table/d35e680/?report=objectonly">Open in a separate window</a></div></div><!--table-wrap mode="anchored" t6--><div class="table-wrap anchored whole_rhythm" id="d35e998"><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" valign="top" colspan="12" rowspan="1"><strong>B. SNP vs. AUC (Panel 2)</strong></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"><strong>Gene symbol</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Chr</strong>.</th><th align="left" valign="top" rowspan="1" colspan="1"><strong>SNP</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Position</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Location</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>MAF<sup>***</sup></strong></th><th align="center" valign="top" colspan="3" rowspan="1"><strong>Rapamycin</strong></th><th align="center" valign="top" colspan="3" rowspan="1"><strong>Everolimus</strong></th></tr><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>P</em></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>R<sup>*</sup></em></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>Q<sup>**</sup></em></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>P</em></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>R<sup>*</sup></em></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>Q<sup>**</sup></em></strong></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">MCTP2</td><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">rs17664713</td><td align="left" valign="top" rowspan="1" colspan="1">93119590</td><td align="left" valign="top" rowspan="1" colspan="1">3&#x02032;-Downstream</td><td align="left" valign="top" rowspan="1" colspan="1">0.15</td><td align="left" valign="top" rowspan="1" colspan="1">4.70E-06</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.28</td><td align="left" valign="top" rowspan="1" colspan="1">0.96</td><td align="left" valign="top" rowspan="1" colspan="1">1.60E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.27</td><td align="left" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">rs17732246</td><td align="left" valign="top" rowspan="1" colspan="1">93120790</td><td align="left" valign="top" rowspan="1" colspan="1">3&#x02032;-Downstream</td><td align="left" valign="top" rowspan="1" colspan="1">0.10</td><td align="left" valign="top" rowspan="1" colspan="1">8.63E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.25</td><td align="left" valign="top" rowspan="1" colspan="1">0.96</td><td align="left" valign="top" rowspan="1" colspan="1">4.60E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.26</td><td align="left" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ABCC1</td><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">rs11075286</td><td align="left" valign="top" rowspan="1" colspan="1">15935225</td><td align="left" valign="top" rowspan="1" colspan="1">5&#x02032;-Upstream</td><td align="left" valign="top" rowspan="1" colspan="1">0.45</td><td align="left" valign="top" rowspan="1" colspan="1">3.93E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.26</td><td align="left" valign="top" rowspan="1" colspan="1">0.96</td><td align="left" valign="top" rowspan="1" colspan="1">6.30E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.25</td><td align="left" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">rs4148330</td><td align="left" valign="top" rowspan="1" colspan="1">15949269</td><td align="left" valign="top" rowspan="1" colspan="1">5&#x02032;-Upstream</td><td align="left" valign="top" rowspan="1" colspan="1">0.50</td><td align="left" valign="top" rowspan="1" colspan="1">2.27E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.26</td><td align="left" valign="top" rowspan="1" colspan="1">0.96</td><td align="left" valign="top" rowspan="1" colspan="1">9.80E-06</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.27</td><td align="left" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BTNL2</td><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">rs2076523</td><td align="left" valign="top" rowspan="1" colspan="1">32478813</td><td align="left" valign="top" rowspan="1" colspan="1">Coding region</td><td align="left" valign="top" rowspan="1" colspan="1">0.40</td><td align="left" valign="top" rowspan="1" colspan="1">2.77E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.26</td><td align="left" valign="top" rowspan="1" colspan="1">0.96</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PITPNM3</td><td align="left" valign="top" rowspan="1" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">rs3809835</td><td align="left" valign="top" rowspan="1" colspan="1">6347607</td><td align="left" valign="top" rowspan="1" colspan="1">Coding region</td><td align="left" valign="top" rowspan="1" colspan="1">0.30</td><td align="left" valign="top" rowspan="1" colspan="1">7.73E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.25</td><td align="left" valign="top" rowspan="1" colspan="1">0.96</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140263168971520"><a target="object" rel="noopener" href="/pmc/articles/PMC3757297/table/d35e998/?report=objectonly">Open in a separate window</a></div></div><!--table-wrap mode="anchored" t6--><div class="table-wrap anchored whole_rhythm" id="d35e1225"><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" valign="top" colspan="18" rowspan="1"><strong>C. Integrated analysis (Panel 3)</strong></th></tr><tr><th align="center" valign="top" colspan="5" rowspan="1"><strong>SNP</strong></th><th align="center" valign="top" colspan="3" rowspan="1"><strong>Genes</strong></th><th align="center" valign="top" colspan="2" rowspan="1"><strong>SNP vs. EXP</strong></th><th align="center" valign="top" colspan="4" rowspan="1"><strong>SNP vs. AUC</strong></th><th align="center" valign="top" colspan="4" rowspan="1"><strong>EXP vs. AUC</strong></th></tr><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th align="center" valign="top" colspan="2" rowspan="1"><strong>Rapamycin</strong></th><th align="center" valign="top" colspan="2" rowspan="1"><strong>Everolimus</strong></th><th align="center" valign="top" colspan="2" rowspan="1"><strong>Rapamycin</strong></th><th align="center" valign="top" colspan="2" rowspan="1"><strong>Everolimus</strong></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"><strong>SNP</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Chr</strong>.</th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Closet gene</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>SNP location</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>MAF<sup>***</sup></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Probe id</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Chr</strong>.</th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Gene symbol</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>P</em></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>R</em><sup>*</sup></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>P</em></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>R</em><sup>*</sup></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>P</em></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>R</em><sup>*</sup></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>P</em></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>R</em><sup>*</sup></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>P</em></strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong><em>R</em><sup>*</sup></strong></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">rs10780752</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">C9orf153</td><td align="left" valign="top" rowspan="1" colspan="1">3&#x02032;-Downstream</td><td align="left" valign="top" rowspan="1" colspan="1">0.31</td><td align="left" valign="top" rowspan="1" colspan="1">222445_at</td><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">SLC39A9</td><td align="left" valign="top" rowspan="1" colspan="1">2.03E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.26</td><td align="left" valign="top" rowspan="1" colspan="1">4.90E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.25</td><td align="left" valign="top" rowspan="1" colspan="1">3.49E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.26</td><td align="left" valign="top" rowspan="1" colspan="1">6.79E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.24</td><td align="left" valign="top" rowspan="1" colspan="1">1.48E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs7543260</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">JUN</td><td align="left" valign="top" rowspan="1" colspan="1">5&#x02032;-Upstream</td><td align="left" valign="top" rowspan="1" colspan="1">0.18</td><td align="left" valign="top" rowspan="1" colspan="1">203881_s_at</td><td align="left" valign="top" rowspan="1" colspan="1">23</td><td align="left" valign="top" rowspan="1" colspan="1">DMD</td><td align="left" valign="top" rowspan="1" colspan="1">6.09E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.24</td><td align="left" valign="top" rowspan="1" colspan="1">9.78E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.24</td><td align="left" valign="top" rowspan="1" colspan="1">2.35E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.26</td><td align="left" valign="top" rowspan="1" colspan="1">9.54E-04</td><td align="left" valign="top" rowspan="1" colspan="1">0.2</td><td align="left" valign="top" rowspan="1" colspan="1">2.98E-04</td><td align="left" valign="top" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs10870177</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">MAN1B1</td><td align="left" valign="top" rowspan="1" colspan="1">Intron</td><td align="left" valign="top" rowspan="1" colspan="1">0.17</td><td align="left" valign="top" rowspan="1" colspan="1">218470_at</td><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">YARS2</td><td align="left" valign="top" rowspan="1" colspan="1">5.26E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.24</td><td align="left" valign="top" rowspan="1" colspan="1">8.04E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.24</td><td align="left" valign="top" rowspan="1" colspan="1">1.99E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.264</td><td align="left" valign="top" rowspan="1" colspan="1">1.72E-04</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.23</td><td align="left" valign="top" rowspan="1" colspan="1">5.87E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.24</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs4144048</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">GYPC</td><td align="left" valign="top" rowspan="1" colspan="1">5&#x02032;-Upstream</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td><td align="left" valign="top" rowspan="1" colspan="1">235790_at</td><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">LOC100131081</td><td align="left" valign="top" rowspan="1" colspan="1">6.37E-05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.24</td><td align="left" valign="top" rowspan="1" colspan="1">6.20E-05</td><td align="left" valign="top" rowspan="1" colspan="1">0.25</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">0.000355</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.21</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140263188793712"><a target="object" rel="noopener" href="/pmc/articles/PMC3757297/table/d35e1225/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TN1"><sup>*</sup><em>Represents the correlation coefficient R-value for associations</em>.</div><div id="TN2"><sup>**</sup><em>Represents the false discovery rate Q-value</em>.</div><div id="TN3"><sup>***</sup><em>Represents the minor allele frequency (MAF)</em>.</div></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC3757297/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140263185099456"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3757297_fgene-04-00166-g0003.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fgene-04-00166-g0003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3757297/bin/fgene-04-00166-g0003.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140263185099456"><a target="object" rel="noopener" href="/pmc/articles/PMC3757297/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC3757297/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p><strong>Schematic diagram of the strategy for selecting candidate genes for functional validation</strong>. A total of 23 candidate genes were selected based on genome-wide associations of expression (Exp) vs. AUC, SNP vs. AUC and an &#x0201c;<span class="underline">I</span>ntegrated&#x0201d; analysis, as described in the text.</p></div></div></div></div><div id="sec-a.q.c.c.c" class="sec"><p></p><h4 id="sec-a.q.c.c.ctitle" class="inline">SNP vs. cytotoxicity </h4><p class="p p-first-last">Next we performed GWA analysis between SNPs and AUC values for both Rapamycin and Everolimus (refer to Figures <a href="/pmc/articles/PMC3757297/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>2C,D</span></a>). Although none of SNPs reached genome-wide significance (<em>P</em> &#x0003c; 10<sup>&#x02212;8</sup>), 127 and 100 SNPs had <em>P</em> &#x0003c; 10<sup>&#x02212;4</sup>, while 8 and 10 SNPs had <em>P</em> &#x0003c; 10<sup>&#x02212;5</sup> with Rapamycin and Everolimus AUC, respectively (Supplementary Tables <a href="#SM1" rid="SM1" class=" supplementary-material">S3</a>, <a href="#SM1" rid="SM1" class=" supplementary-material">S4</a>). Seven genes for Rapamycin and 4 genes for Everolimus contained multiple SNPs with <em>P</em> &#x0003c; 10<sup>&#x02212;4</sup>. Among these genes, <em>ABCC1</em> and <em>MCTP2</em> were common to both drugs, and those genes were both expressed in the LCLs. Therefore we included these two genes in our functional studies. The majority of the top associated SNPs were located in the non-coding regions of genes, except for 2 non-synonymous SNPs, rs2076523 (<em>P</em> = 2.77 &#x000d7; 10<sup>&#x02212;5</sup>) and rs3809835 (<em>P</em> = 7.73 &#x000d7; 10<sup>&#x02212;5</sup>) both for Rapamycin. These SNPs were located in the coding region of <em>BTNL2</em> and <em>PITPNM3</em>, respectively. For this reason, these 2 genes were also selected for inclusion in the functional studies of their potential possibility to influence cytotoxicity. A total of 4 genes were selected for functional validation based on SNP vs. cytotoxicity associations, as summarized in Table <a href="/pmc/articles/PMC3757297/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1B</span></span><span>1B</span></a>.</p></div><div id="sec-a.q.c.c.d" class="sec"><p></p><h4 id="sec-a.q.c.c.dtitle" class="inline">Integrated analysis </h4><p class="p p-first">In order to determine if the SNPs that were associated with cytotoxicity might regulate the expression of genes whose mRNA expression influenced cytotoxicity, &#x0201c;integrated&#x0201d; analyses were performed among SNPs, mRNA gene expression and AUC values for the two mTOR inhibitors studied, as described previously (Storey). Specifically, for the top mTOR associated SNPs (i.e., SNPs with <em>P</em> &#x0003c; 10<sup>&#x02212;4</sup>), we determined their association with gene expression using <em>P</em> &#x0003c; 10<sup>&#x02212;4</sup> as a cutoff. These SNP-associated genes were then narrowed down to those whose mRNA gene expression probe sets were also associated with mTOR cytotoxicity (<em>P</em> &#x0003c; 10<sup>&#x02212;3</sup>). As the focus of these analyses was exploratory in nature and designed to generate a list of potential candidate genes for functional follow-up, we used less stringent criteria for statistical significance for this selection process.</p><p class="p p-last">Twenty SNP-gene pairs for Rapamycin and Everolimus were identified through this integrative analysis (Supplementary Tables <a href="#SM1" rid="SM1" class=" supplementary-material">S5</a>, <a href="#SM1" rid="SM1" class=" supplementary-material">S6</a>), with 3 common SNP-gene pairs overlapping between both drugs: rs10780752-<em>SLC39A9</em>, rs7543260-<em>DMD</em>, and rs10870177-<em>YARS2</em>, as listed in Table <a href="/pmc/articles/PMC3757297/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1C.</span></span><span>1C</span></a>. The <em>SLC39A9</em>, <em>DMD</em>, and <em>YARS2</em> genes, and genes harboring the SNPs (<em>C9orf153</em>, <em>JUN</em>, and <em>MAN1B)</em> were all included for functional validation. In addition, we also included <em>GYPC</em> during our functional study, since <em>GYPC</em> was one of the 7 genes containing multiple significant SNPs that were associated with Rapamycin cytotoxicity (<em>P</em> &#x0003c; 10<sup>&#x02212;4</sup>) and the 2 significant SNPs (rs4144048 and rs2219206) located in <em>GYPC</em> were also associated with expression levels of the <em>PIP4K2A</em> and <em>LOC100131081</em> genes (<em>P</em> &#x0003c; 10<sup>&#x02212;4</sup>) for Rapamycin.</p></div><div id="sec-a.q.c.c.e" class="sec"><p></p><h4 id="sec-a.q.c.c.etitle" class="inline">Functional validation of candidate genes in tumor and primary cell lines </h4><p class="p p-first">In summary, we selected 23 genes based on the strategy shown in Figure <a href="/pmc/articles/PMC3757297/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure3</span></span><span>3</span></a> to perform siRNA screening, followed by MTS and colony formation assays to determine the effect of these candidate genes on the cytotoxicity of mTOR inhibitors. We performed these studies using Caki2 renal carcinoma cells, U87 glioblastoma cells, and IMR90 primary fibroblast cells. The two cancer cell lines were chosen because mTOR inhibitors are used to treat glioblastoma and renal carcinoma. The IMR90 cell line was chosen to be a normal cell line used in the study. Eleven out of twenty-three genes were verified to have a significant impact on the cytotoxicity of Rapamycin and/or Everolimus using the MTS assays in at least one cell line. Figure <a href="/pmc/articles/PMC3757297/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure4A</span></span><span>4A</span></a> shows the data for representative genes with a significant influence on the cytotoxicity of each drug treatment in each cell line. Specifically, knockdown of 5 genes, <em>ECOP</em>, <em>MGLL</em>, <em>SLC39A9</em>, <em>ZNF765</em>, and <em>MAN1B1</em> sensitized the cells to Rapamycin and/or Everolimus in at least 2 cell lines (<em>P</em> &#x0003c; 0.05). Down-regulation of <em>NDUFAF2</em> and <em>SLC39A9</em> desensitized the cells to Rapamycin treatment in IMR90 and U87 cell lines, respectively (<em>P</em> &#x0003c; 0.05). Additional genes that significantly altered cell sensitivities are shown in Supplementary Figures <a href="#SM1" rid="SM1" class=" supplementary-material">S2</a>, <a href="#SM1" rid="SM1" class=" supplementary-material">S3</a>, <a href="#SM1" rid="SM1" class=" supplementary-material">S4</a> for each cell line. All of the genes that were functionally verified are listed in Table <a href="/pmc/articles/PMC3757297/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table2</span></span><span>2</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC3757297/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140263191304016"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3757297_fgene-04-00166-g0004.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fgene-04-00166-g0004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3757297/bin/fgene-04-00166-g0004.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140263191304016"><a target="object" rel="noopener" href="/pmc/articles/PMC3757297/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC3757297/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><p><strong>Functional validation of candidate genes with siRNA knockdown in IMR90, U87 and Caki2 cell lines, followed by cytotoxicity assay (A) and colony formation assays (B)</strong>. Data shown are representative experiments for selected genes in each cell line. siRNA knockdown for each individual gene (dashed line) were compared with negative control siRNA (solid line). <strong>(C)</strong>. Knockdown efficiency was determined by qRT-PCR. Experiments were repeated in triplicate with at least two independent experiments. Significant <em>P</em>-values are listed for every gene. Error bars indicate standard error of the mean (SEM) values. Significance of AUC values between the control and specific siRNA was determined by student <em>t</em>-test.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p><strong>Summary of functional validation of candidate genes</strong>.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Gene</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Association</strong></th><th align="center" valign="top" colspan="3" rowspan="1"><strong>Cytotoxicity (siRNA KD)</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Colony formation (siRNA KD)</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>miR-10a regulation</strong></th></tr><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Caki2</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>IMR90</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>U87</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Caki2</strong></th><th align="left" valign="top" rowspan="1" colspan="1"><strong>Caki2</strong></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">mRNA Exp vs. AUC (13 genes)</td><td align="left" valign="top" rowspan="1" colspan="1">BTG2</td><td align="left" valign="top" rowspan="1" colspan="1">Exp vs. AUC (<em>R</em> = 0.27)</td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193;</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">ECOP</td><td align="left" valign="top" rowspan="1" colspan="1">Exp vs. AUC (<em>R</em> = 0.29)</td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193; Eve&#x02193;</td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Eve&#x02193;</td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193;</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">FBXW7</td><td align="left" valign="top" rowspan="1" colspan="1">Exp vs. AUC (<em>R</em> = 0.26)</td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193;</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">GIMAP1</td><td align="left" valign="top" rowspan="1" colspan="1">Exp vs. AUC (<em>R</em> = &#x02212;0.24)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">GIMAP6</td><td align="left" valign="top" rowspan="1" colspan="1">Exp vs. AUC (<em>R</em> = &#x02212;0.26)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">GIMAP7</td><td align="left" valign="top" rowspan="1" colspan="1">Exp vs. AUC (<em>R</em> = &#x02212;0.25)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">MGLL</td><td align="left" valign="top" rowspan="1" colspan="1">Exp vs. AUC (<em>R</em> = 0.23)</td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193; Eve&#x02193;</td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Eve&#x02193;</td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193; Eve&#x02193;</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">NDUFAF2</td><td align="left" valign="top" rowspan="1" colspan="1">Exp vs. AUC (<em>R</em> = &#x02212;0.24)</td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02191;</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">PBX3</td><td align="left" valign="top" rowspan="1" colspan="1">Exp vs. AUC (<em>R</em> = 0.28)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">PHLDA1</td><td align="left" valign="top" rowspan="1" colspan="1">Exp vs. AUC (<em>R</em> = 0.24)</td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Eve&#x02193;</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">SLC39A9</td><td align="left" valign="top" rowspan="1" colspan="1">Exp vs. AUC and 3 way (<em>R</em> = 0.24)</td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193;</td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193;</td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02191; Eve&#x02191;</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">STAU</td><td align="left" valign="top" rowspan="1" colspan="1">Exp vs. AUC (<em>R</em> = 0.25)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">ZNF765</td><td align="left" valign="top" rowspan="1" colspan="1">Exp vs. AUC (<em>R</em> = 0.25)</td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193;</td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193; Eve&#x02193;</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SNP vs. AUC (4 genes)</td><td align="left" valign="top" rowspan="1" colspan="1">ABCC1</td><td align="left" valign="top" rowspan="1" colspan="1">SNP vs. AUC</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193;</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">MCPT2</td><td align="left" valign="top" rowspan="1" colspan="1">SNP vs. AUC</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Eve&#x02193;</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">BTNL2</td><td align="left" valign="top" rowspan="1" colspan="1">SNP vs. AUC (non-synonymous)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">PITPNM3</td><td align="left" valign="top" rowspan="1" colspan="1">SNP vs. AUC (non-synonymous)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193;</td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Integrated analysis (Exp, SNP and AUC) (6 genes)</td><td align="left" valign="top" rowspan="1" colspan="1">c9orf153</td><td align="left" valign="top" rowspan="1" colspan="1">Integrated analysis (SNP)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">GYPC</td><td align="left" valign="top" rowspan="1" colspan="1">Integrated analysis (SNP)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">JUN</td><td align="left" valign="top" rowspan="1" colspan="1">Integrated analysis (SNP)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">MAN1B1</td><td align="left" valign="top" rowspan="1" colspan="1">Integrated analysis (SNP)</td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193; Eve&#x02193;</td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193; Eve&#x02193;</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">YARS2</td><td align="left" valign="top" rowspan="1" colspan="1">Integrated analysis (<em>R</em> = &#x02212;0.24)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">DMD</td><td align="left" valign="top" rowspan="1" colspan="1">Integrated analysis (<em>R</em> = 0.20)</td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193;</td><td rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">Rap&#x02193; Eve&#x02193;</td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140263192725696"><a target="object" rel="noopener" href="/pmc/articles/PMC3757297/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p><em>&#x0201c;Rap&#x0201d; represents Rapamycin treatment; &#x0201c;Eve&#x0201d; represents Everolimus treatment. &#x0201c;&#x02193;&#x0201d; indicates siRNA knockdown of the gene sensitizes to the Rapamycin and/or Everolimus response (P &#x0003c; 0.05). &#x0201c;&#x02191;&#x0201d; indicates siRNA knockdown of gene desensitizes to the Rapamycin and/or Everolimus response (P &#x0003c; 0.05). &#x0201c;Yes&#x0201d; indicates miR-10a was verified to regulate gene expression. Blank indicates no significant change in cytotoxicity after knockdown</em>.</p></div></div><p class="p p-last">Furthermore, colony formation assays were also performed for the genes expressed in the Caki2 cell line, due to the relative ease of colony formation with this cell line compared to the other cell lines studied. We confirmed that knockdown of <em>ECOP</em> and <em>MGLL</em> significantly reduced colony formation as compared with the negative siRNA control (<em>P</em> &#x0003c; 0.05) after treatment with Rapamycin and/or Everolimus (Figures <a href="/pmc/articles/PMC3757297/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>4B,C</span></a>), an observation that was consistent with the cytotoxicity assay results for the same cell line. In addition, even though the <em>ABCC1</em>, <em>PITPNM3</em>, and <em>DMD</em> genes were not verified by MTS assay, they were also shown to significantly decrease colony formation after Rapamycin or/and Everolimus treatment. However, we realize that the performance of colony formation assays using only the Caki2 cell line may be biased since not all the candidate genes were well expressed in this particular cell line. Overall, we functionally validated 13 out of 23 candidate genes selected from the GWAS analyses in at least one cell line with at least one assay (refer to Table <a href="/pmc/articles/PMC3757297/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table2</span></span><span>2</span></a>).</p></div><div id="sec-a.q.c.c.f" class="sec sec-last"><p></p><h4 id="sec-a.q.c.c.ftitle" class="inline">Effect of miR-10a on cytotoxicity of rapamycin and everolimus and gene regulation </h4><p class="p p-first">MicroRNAs are a class of non-coding RNAs that regulate genes and/or protein expression by binding with mRNA to mediate mRNA degradation or block mRNA translation (Bartel, <a href="#B4" rid="B4" class=" bibr popnode">2004</a>, <a href="#B5" rid="B5" class=" bibr popnode">2009</a>). Therefore, microRNAs could also contribute to response to mTOR inhibitor effect. The microRNA screening procedure that we used is outlined graphically in Figure <a href="/pmc/articles/PMC3757297/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure5A.</span></span><span>5A</span></a>. Briefly, 228 association tests were conducted between each microRNA expression probe and AUC values for both Everolimus and Rapamycin using the 262 cell lines for which we had both cytotoxicity and microRNA data sets. One microRNA expression probe, ILMN_3167552 (miR-10a), was highly associated with Everolimus AUC (<em>P</em> = 1.04 &#x000d7; 10<sup>&#x02212;4</sup>, <em>R</em> = 0.2377), a value that reached genome-wide significance (Figure <a href="/pmc/articles/PMC3757297/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure5B).</span></span><span>5B</span></a>). This same microRNA probe was also the most significant probe associated with Rapamycin AUC (<em>P</em> = 4.25 &#x000d7; 10<sup>&#x02212;4</sup>, <em>R</em> = 0.2610). MiR-10a was further validated for its functional impact on cytotoxicity for both drugs in the Caki2 cell line. MiR-10a mimic significantly desensitized the cell to Rapamycin and Everolimus (<em>P</em> &#x0003c; 0.05), as shown in Figure <a href="/pmc/articles/PMC3757297/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure5D</span></span><span>5D</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC3757297/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140263231286992"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3757297_fgene-04-00166-g0005.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fgene-04-00166-g0005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3757297/bin/fgene-04-00166-g0005.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140263231286992"><a target="object" rel="noopener" href="/pmc/articles/PMC3757297/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC3757297/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5</a></div><!--caption a7--><div class="caption"><p><strong>MicroRNA screening and functional validation of miR-10a. (A)</strong> Schematic diagram of the strategy used to select microRNAs for functional validation. <strong>(B)</strong> Genome-wide associations of microRNAs with AUC values for Rapamycin and Everolimus. MiR-10a was the most significant microRNA associated with AUC values for both Rapamycin and Everolimus. The x-axis represents 226 microRNA probes, and the y-axis represents the &#x02212;log<sub>10</sub>(<em>P</em>-value) for the association of individual microRNA probe sets. A &#x02212;log<sub>10</sub>(<em>P</em>-value) of 3.66 is highlighted with a horizontal line, indicating a <em>p</em>-value with genome-wide significance after Bonferroni correction for 228 tests. <strong>(C)</strong> Effect of Rapamycin on miR-10a Expression. MiR-10a expression was significantly enhanced by Rapamycin treatment compared with controls in Caki2 and U87 cell lines. <strong>(D)</strong> Effect of miR-10a on the cytotoxicity of Rapamycin and Everolimus. miR-10a overexpression (mimic) desensitized Caki2 cell to Rapamycin and Everolimus. <strong>(E)</strong> Gene regulation by miR-10a. miR-10a inhibitor &#x0201c;rescued&#x0201d; gene expression and mimic repressed gene expression in Caki2 cell line compared with inhibitor negative control or mimic negative control. The arrow indicates the positive control, the <em>HOXA1</em> gene. Experiments were performed in duplicate and were repeated 3 times. Error bars indicate mean &#x000b1;SEM values. <sup>*</sup><em>P</em> &#x0003c; 0.05; <sup>**</sup><em>P</em> &#x0003c; 0.001.</p></div></div></div><p class="p p-last">To further pursue the effect of microRNA on gene expression, we performed an association study of miR-10a with mRNAs whose expression levels were highly associated with Rapamycin and Everolimus cytotoxicity (<em>P</em> &#x0003c; 10<sup>&#x02212;4</sup>). Thirty-one mRNA expression probe sets (28 genes) were determined to be highly associated with miR-10a expression (<em>P</em> &#x0003c; 10<sup>&#x02212;4</sup>) (Supplementary Table <a href="#SM1" rid="SM1" class=" supplementary-material">S7</a>). Specifically, 9 out of the 28 genes had already been included for siRNA screening, as highlighted in Supplementary Table <a href="#SM1" rid="SM1" class=" supplementary-material">S7</a>. Therefore, those 9 genes were tested further for the effect of miR-10a on gene regulation. <em>HOXA1</em>, a known target for miR-10a, was used as a positive control gene (Mansfield et al., <a href="#B30" rid="B30" class=" bibr popnode">2004</a>; Garzon et al., <a href="#B16" rid="B16" class=" bibr popnode">2006</a>). All of the genes (including the positive control, <em>HOXA1</em>) were regulated by miR-10a in the same manner: miR-10a mimic significantly suppressed gene expression, while miR-10a inhibitor rescued gene expression (<em>P</em> &#x0003c; 0.05), as shown in Figure <a href="/pmc/articles/PMC3757297/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure5E.</span></span><span>5E</span></a>. Four of those 9 genes (<em>PHLDA1</em>, <em>FBXW7</em>, <em>NDUFAF2</em>, and <em>MGLL</em>) were shown to have an effect on response to Rapamycin or Everolimus in one or more cell lines (Table <a href="/pmc/articles/PMC3757297/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2).</span></span><span>2</span></a>). Down-regulation of 3 of the 4 genes (all except <em>NDUFAF2</em>) desensitized the cells to mTOR inhibitors. In addition, Rapamycin treatment significantly enhanced miR-10a expression in a dose dependent manner (Figure <a href="/pmc/articles/PMC3757297/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure5C,</span></span><span>5C</span></a>, <em>P</em> &#x0003c; 0.05), suggesting that miR-10a might be suppressed by mTORC1 activation. We also tested the effect of miR-10a on mTORC1 signaling by measuring phosphorylated S6K and 4EBP1 and found that knockdown or overexpression of miR-10a did not result in a change of mTORC1 activity (data not shown).</p></div></div></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Discussion</h2><p class="p p-first">mTOR inhibitors are a class of novel targeted agents that have shown promising results in cancer treatment. However, the response to mTOR inhibitors varies widely, ranging from lack of efficacy to the occurrence of undesired side effects. Genetic variation is one of the major factors that can play an important role in determining drug response (Wang et al., <a href="#B52" rid="B52" class=" bibr popnode">2011</a>). However, there are only few published data on the influence of genetics on mTOR inhibition effect. Examples include <em>CYP3A5</em> and <em>ABCB1</em> genotype effect on the pharmacokinetics of Rapamycin (Sirolimus) as an immunosuppressant for organ transplantation (Anglicheau et al., <a href="#B2" rid="B2" class=" bibr popnode">2005</a>; Mourad et al., <a href="#B34" rid="B34" class=" bibr popnode">2005</a>; Le Meur et al., <a href="#B26" rid="B26" class=" bibr popnode">2006</a>; Renders et al., <a href="#B43" rid="B43" class=" bibr popnode">2007</a>; Miao et al., <a href="#B33" rid="B33" class=" bibr popnode">2008</a>). Therefore, it would be important to identify and understand the biology underlying the possible role of genetic variation in determining drug response to mTOR inhibitors.</p><p>In this study, we took a genome-wide approach to screen for pharmacogenomic candidates that might alter the effect of mTOR inhibitors by taking advantage of extensive genomic data that we have obtained for 272 LCLs (SNPs, gene expression and microRNA expression), together with cytotoxicity data that we generated with two mTOR inhibitors, Rapamycin and Everolimus (Figures <a href="/pmc/articles/PMC3757297/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -4em;">(Figures1,</span></span><span>1</span></a>, <a href="/pmc/articles/PMC3757297/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0.5em;">,2).</span></span><span>2</span></a>). We used these two drugs to help inform the candidates identified between the drugs. This GWA analysis served as a hypothesis generating step, allowing us to screen for genomic candidates (SNP and genes) that showed strong associations with mTOR inhibitor-induced cytotoxicity. We then focused primarily on common candidates identified for both drugs. Genes such as <em>BTG2</em> and <em>FBXW7</em> that are known to affect the mTOR signaling pathway were also found to be associated with cytotoxicity of mTOR inhibitors in our study (Kim et al., <a href="#B25" rid="B25" class=" bibr popnode">2008</a>; Mao et al., <a href="#B31" rid="B31" class=" bibr popnode">2008</a>), suggesting that our association approach performed with 272 LCLs was capable of generating biologically relevant candidates for follow-up study.</p><p>The LCLs have limitations, as we have previously discussed (Niu et al., <a href="#B36" rid="B36" class=" bibr popnode">2010</a>). For example, EBV transformation can induce chromosomal instability and cellular changes (Sie et al., <a href="#B47" rid="B47" class=" bibr popnode">2009</a>). In addition, other factors such as cell growth rate and ATP level can have an effect on cytotoxicity (Choy et al., <a href="#B9" rid="B9" class=" bibr popnode">2008</a>). Since these cell lines do not necessarily represent the response of other types of tissues or cells (Dimas et al., <a href="#B13" rid="B13" class=" bibr popnode">2009</a>), we selected the top candidate genes based on our analyses to determine their contribution to variation in response to mTOR inhibitors. Two clinically relevant tumor cell lines, renal carcinoma (Caki2) and glioblastoma (U87), were selected for functional validation (Supplementary Figures <a href="#SM1" rid="SM1" class=" supplementary-material">S2</a>, <a href="#SM1" rid="SM1" class=" supplementary-material">S3</a>) since mTOR inhibitors are used as a treatment for these two types of tumors (Pantuck et al., <a href="#B38" rid="B38" class=" bibr popnode">2006</a>; Brugarolas et al., <a href="#B6" rid="B6" class=" bibr popnode">2008</a>; Cloughesy et al., <a href="#B11" rid="B11" class=" bibr popnode">2008</a>) and because our data suggested that these two cell lines were relatively more sensitive to mTOR inhibitor treatment. A fibroblast cell line (IMR90) was also included as a comparison to the tumor cell lines (Supplementary Figure S4). The two tumor cell lines, Caki2 and U87, tended to show similar results for several of the genes tested: <em>ECOP</em>, <em>MGLL</em>, and <em>MAN1B</em>. Our study showed that knockdown of these genes sensitized both Caki2 and U87 cells to mTOR inhibitors. <em>ECOP</em> (EGFR-coamplified and overexpressed protein), a gene which is amplified and overexpressed in at least a third of glioblastomas with EGFR amplification (Eley et al., <a href="#B14" rid="B14" class=" bibr popnode">2002</a>), is known to be a key regulator of NF-&#x003ba;B transcriptional activity that can contribute to cell survival (Park and James, <a href="#B39" rid="B39" class=" bibr popnode">2005</a>). IMR90 cells, on the other hand, seemed to be impacted by a different panel of genes, <em>BTG2, FBXW7, NDUFAF2, PHLDA1</em>, and <em>DMD</em>, whose knockdown did not have a significant impact in the two tumor cell lines, suggesting cell line-specific effects. Many of these genes have not been previously reported to interfere with the mTOR pathway except for <em>FBXW7</em> (F-box and WD repeat domain containing 7), which is known to target mTOR for degradation and which cooperates with PTEN for tumor suppression (Mao et al., <a href="#B31" rid="B31" class=" bibr popnode">2008</a>), and <em>BTG2</em> (B-cell translocation gene 2), which has been reported to inhibit AKT phosphorylation and mTOR signaling. Our results were compatible with the conclusion that down-regulation of FBXW7 restored the target for mTOR inhibitors, thus sensitizing cells to mTOR inhibitors, while knockdown of BTG2 activated the mTOR pathway which might cause the cells to become &#x0201c;addicted&#x0201d; to the mTOR pathway and, therefore, to benefit from mTOR inhibition. It is also worth noting that knockdown of <em>ZNF765</em> (zinc finger protein 765) was found to sensitize cells to mTOR inhibitors in both the IMR90 and U87 cell lines (Table <a href="/pmc/articles/PMC3757297/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2).</span></span><span>2</span></a>). <em>ZNF765</em> is located on chromosome 19 and little is known with regard to its function. Therefore, its involvement in the mTOR pathway and response to mTOR inhibitors needs to be investigated further in the future.</p><p class="p p-last">Besides mRNA expression and SNPs, other genetic mechanisms, such as copy number variation, epigenetic effects (CpG methylation sites) and microRNAs might also influence response to mTOR inhibitor (Shenouda and Alahari, <a href="#B46" rid="B46" class=" bibr popnode">2009</a>). Despite the well-recognized importance of microRNAs and mTOR in cancer, very few studies have linked microRNAs with mTOR activity. MiR-99 was reported to mediate down-regulation of mTOR/FGFR3 and suppress tumor growth; miR-100 is known to inhibit mTOR signaling and enhance sensitivity to Everolimus in clear cell ovarian cancer (Nagaraja et al., <a href="#B35" rid="B35" class=" bibr popnode">2010</a>; Oneyama et al., <a href="#B37" rid="B37" class=" bibr popnode">2011</a>); and mTORC1 was recently reported to regulate miR-1 in skeletal myogenesis (Sun et al., <a href="#B50" rid="B50" class=" bibr popnode">2010</a>). Therefore, in this study we also attempted to determine whether microRNA might affect response to mTOR inhibitors. One microRNA (miR-10a) was shown to desensitize response to mTOR inhibitors (Figure <a href="/pmc/articles/PMC3757297/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure5D),</span></span><span>5D</span></a>), and also affected the expression of several candidate genes that influenced sensitivity to mTOR inhibitors (Figure <a href="/pmc/articles/PMC3757297/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure5E).</span></span><span>5E</span></a>). MiR-10a, a member of the miR-10 family members, maps to chromosome 17 upstream of the <em>HOX</em> gene cluster and putatively regulates expression of the <em>HOXA1</em>, <em>HOXA3</em>, and <em>HOXD10</em> genes (Garzon et al., <a href="#B16" rid="B16" class=" bibr popnode">2006</a>; Han et al., <a href="#B19" rid="B19" class=" bibr popnode">2007</a>). It is upregulated in glioblastoma, anaplastic astrocytomas and hepatocellular carcinoma (Ciafre et al., <a href="#B10" rid="B10" class=" bibr popnode">2005</a>; Gaur et al., <a href="#B17" rid="B17" class=" bibr popnode">2007</a>; Lund, <a href="#B29" rid="B29" class=" bibr popnode">2010</a>), and is known to be involved in the development of chronic and acute myeloid leukemia (Agirre et al., <a href="#B1" rid="B1" class=" bibr popnode">2008</a>; Jongen-Lavrencic et al., <a href="#B24" rid="B24" class=" bibr popnode">2008</a>). We also demonstrated that miR-10a can be induced by mTOR inhibitors and that genes highly associated with miR-10a were all negatively regulated by miR-10a. Based on this evidence, we hypothesize that mTOR inhibitors upregulate miR-10a expression, which in turn desensitizes cells to mTOR inhibitors response. This process probably occurs through the regulation of a set of genes whose expression levels are also critical in determining mTOR inhibitor response (Supplementary Table <a href="#SM1" rid="SM1" class=" supplementary-material">S7</a>). Therefore, upregulation of miR-10a might be one mechanism for acquired resistance after Rapamycin therapy. Among the 9 genes that we tested, 5 had predicted binding sites for miR-10a. However, several genes were found experimentally to be negatively regulated by miR-10a, which was not consistent with the positive association values between miR-10a and mRNA expression (ex. FBXW7, <em>R</em> = 0.367; STAU1, <em>R</em> = 0.273; PHLDA1, <em>R</em> = 0.431, etc) observed in our LCLs. This might be due to the different cell specificity in terms of transcription regulation. We have also shown that inhibition of mTOR by Rapamycin upregulated miR-10a (Figure <a href="/pmc/articles/PMC3757297/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure5C),</span></span><span>5C</span></a>), a process that might create a feedback loop resulting in desensitization of cells to mTOR inhibitors. However, the exact mechanisms by which miR-10a determines mTOR inhibitor response still need to be investigated in future studies.</p></div><div id="s5" class="tsec sec"><h2 class="head no_bottom_margin" id="s5title">Conclusions</h2><p class="p p-first-last">In summary, a pharmacogenomic approach based on the use of genomic data rich LCLs allowed us to identify a series of novel genetic candidates and a microRNAs that might contribute to variation in response to mTOR inhibitors. Functional validation of these candidates demonstrated the feasibility of utilizing this cell-line based model system and a GWA approach to generate hypotheses. These findings might help to enhance our understanding of the regulation of the mTOR pathway and of the mechanisms underlying variation in response to mTOR inhibitors. Obviously this study represents an early attempt to trying to identify biomarkers for response to mTOR inhibitors. These candidates can now be tested in clinical settings in future studies and, if confirmed, these studies could enhance our ability to individualize treatment with mTOR inhibitors.</p></div><div id="sec-a.q.f" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.q.ftitle">Authors&#x02032; contributions</h2><p class="p p-first">Jing Jiang and Liewei Wang designed the study and wrote the manuscript. Jing Jiang and Pamela A. Long performed the experiments. Brooke L. Fridley, Ryan P. Abo, Abra Brisbin, and Anthony Batzler performed the statistical analyses. Ryan Abo conducted the bioinformatic analysis. Qiping Feng performed the miRNA array assay. All the authors read, revised the draft manuscript and approved the final version.</p><div id="sec-a.q.f.c" class="sec sec-last"><h3 id="sec-a.q.f.ctitle">Conflict of interest statement</h3><p class="p p-first-last">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></div></div><div id="ack-a.r.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.r.atitle">Acknowledgments</h2><div class="sec"><p>This work was supported by NIH grants R01 CA138461 and U19 GM61388 (The Pharmacogenomics Research Network).</p></div></div><div id="s6" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="s6title">Supplementary material</h2><!--/article/back/sec/--><p class="p p-first">The Supplementary Material for this article can be found online at: <a href="http://www.frontiersin.org/Pharmacogenetics_and_Pharmacogenomics/10.3389/fgene.2013.00166/abstract" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.frontiersin.org/Pharmacogenetics_and_Pharmacogenomics/10.3389/fgene.2013.00166/abstract</a></p><div class="sec suppmat" id="SM1"><div class="sup-box half_rhythm" id="media-a.r.b.c.a"><a href="/pmc/articles/PMC3757297/bin/DataSheet1.PDF" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(275K, PDF)</sup></div></div></div><div id="ref-list-a.r.c" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.r.ctitle">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="B1"><span class="mixed-citation">Agirre X., Jimenez-Velasco A., San Jose-Eneriz E., Garate L., Bandres E., Cordeu L., et al. (2008). <span class="ref-title">Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth</span>. <span class="ref-journal">Mol. Cancer Res</span>. <span class="ref-vol">6</span>, 1830&#x02013;1840
 10.1158/1541-7786.MCR-08-0167 [<a href="https://pubmed.ncbi.nlm.nih.gov/19074828" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F1541-7786.MCR-08-0167" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Cancer+Res&amp;title=Down-regulation+of+hsa-miR-10a+in+chronic+myeloid+leukemia+CD34++cells+increases+USF2-mediated+cell+growth&amp;author=X.+Agirre&amp;author=A.+Jimenez-Velasco&amp;author=E.+San+Jose-Eneriz&amp;author=L.+Garate&amp;author=E.+Bandres&amp;volume=6&amp;publication_year=2008&amp;pages=1830-1840&amp;pmid=19074828&amp;doi=10.1158/1541-7786.MCR-08-0167&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B2"><span class="mixed-citation">Anglicheau D., Le Corre D., Lechaton S., Laurent-Puig P., Kreis H., Beaune P., et al. (2005). <span class="ref-title">Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy</span>. <span class="ref-journal">Am. J. Transplant</span>. <span class="ref-vol">5</span>, 595&#x02013;603
 10.1111/j.1600-6143.2005.00745.x [<a href="https://pubmed.ncbi.nlm.nih.gov/15707415" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fj.1600-6143.2005.00745.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Transplant&amp;title=Consequences+of+genetic+polymorphisms+for+sirolimus+requirements+after+renal+transplant+in+patients+on+primary+sirolimus+therapy&amp;author=D.+Anglicheau&amp;author=D.+Le+Corre&amp;author=S.+Lechaton&amp;author=P.+Laurent-Puig&amp;author=H.+Kreis&amp;volume=5&amp;publication_year=2005&amp;pages=595-603&amp;pmid=15707415&amp;doi=10.1111/j.1600-6143.2005.00745.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B3"><span class="mixed-citation">Ballman K. V., Grill D. E., Oberg A. L., Therneau T. M. (2004). <span class="ref-title">Faster cyclic loess: normalizing RNA arrays via linear models</span>. <span class="ref-journal">Bioinformatics</span>
<span class="ref-vol">20</span>, 2778&#x02013;2786
 10.1093/bioinformatics/bth327 [<a href="https://pubmed.ncbi.nlm.nih.gov/15166021" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fbioinformatics%2Fbth327" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Faster+cyclic+loess:+normalizing+RNA+arrays+via+linear+models&amp;author=K.+V.+Ballman&amp;author=D.+E.+Grill&amp;author=A.+L.+Oberg&amp;author=T.+M.+Therneau&amp;volume=20&amp;publication_year=2004&amp;pages=2778-2786&amp;pmid=15166021&amp;doi=10.1093/bioinformatics/bth327&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B4"><span class="mixed-citation">Bartel D. P. (2004). <span class="ref-title">MicroRNAs: genomics, biogenesis, mechanism, and function</span>. <span class="ref-journal">Cell</span>
<span class="ref-vol">116</span>, 281&#x02013;297
 10.1016/S0092-8674(04)00045-5 [<a href="https://pubmed.ncbi.nlm.nih.gov/14744438" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0092-8674(04)00045-5" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=MicroRNAs:+genomics,+biogenesis,+mechanism,+and+function&amp;author=D.+P.+Bartel&amp;volume=116&amp;publication_year=2004&amp;pages=281-297&amp;pmid=14744438&amp;doi=10.1016/S0092-8674(04)00045-5&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B5"><span class="mixed-citation">Bartel D. P. (2009). <span class="ref-title">MicroRNAs: target recognition and regulatory functions</span>. <span class="ref-journal">Cell</span>
<span class="ref-vol">136</span>, 215&#x02013;233
 10.1016/j.cell.2009.01.002 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3794896/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19167326" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.cell.2009.01.002" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=MicroRNAs:+target+recognition+and+regulatory+functions&amp;author=D.+P.+Bartel&amp;volume=136&amp;publication_year=2009&amp;pages=215-233&amp;pmid=19167326&amp;doi=10.1016/j.cell.2009.01.002&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B6"><span class="mixed-citation">Brugarolas J., Lotan Y., Watumull L., Kabbani W. (2008). <span class="ref-title">Sirolimus in metatastic renal cell carcinoma</span>. <span class="ref-journal">J. Clin. Oncol</span>. <span class="ref-vol">26</span>, 3457&#x02013;3460
 10.1200/JCO.2008.16.4590 [<a href="https://pubmed.ncbi.nlm.nih.gov/18612163" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1200%2FJCO.2008.16.4590" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Clin.+Oncol&amp;title=Sirolimus+in+metatastic+renal+cell+carcinoma&amp;author=J.+Brugarolas&amp;author=Y.+Lotan&amp;author=L.+Watumull&amp;author=W.+Kabbani&amp;volume=26&amp;publication_year=2008&amp;pages=3457-3460&amp;pmid=18612163&amp;doi=10.1200/JCO.2008.16.4590&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B7"><span class="mixed-citation">Chapman T. M., Perry C. M. (2004). <span class="ref-title">Everolimus</span>. <span class="ref-journal">Drugs</span>
<span class="ref-vol">64</span>, 861&#x02013;872 discussion: 873&#x02013;864.  [<a href="https://pubmed.ncbi.nlm.nih.gov/15059040" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Everolimus&amp;author=T.+M.+Chapman&amp;author=C.+M.+Perry&amp;volume=64&amp;publication_year=2004&amp;pages=861-872&amp;pmid=15059040&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B8"><span class="mixed-citation">Cho P. F., Poulin F., Cho-Park Y. A., Cho-Park I. B., Chicoine J. D., Lasko P., et al. (2005). <span class="ref-title">A new paradigm for translational control: inhibition via 5&#x02032;-3&#x02032; mRNA tethering by Bicoid and the eIF4E cognate 4EHP</span>. <span class="ref-journal">Cell</span>
<span class="ref-vol">121</span>, 411&#x02013;423
 10.1016/j.cell.2005.02.024 [<a href="https://pubmed.ncbi.nlm.nih.gov/15882623" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.cell.2005.02.024" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=A+new+paradigm+for+translational+control:+inhibition+via+5&#x02032;-3&#x02032;+mRNA+tethering+by+Bicoid+and+the+eIF4E+cognate+4EHP&amp;author=P.+F.+Cho&amp;author=F.+Poulin&amp;author=Y.+A.+Cho-Park&amp;author=I.+B.+Cho-Park&amp;author=J.+D.+Chicoine&amp;volume=121&amp;publication_year=2005&amp;pages=411-423&amp;pmid=15882623&amp;doi=10.1016/j.cell.2005.02.024&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B9"><span class="mixed-citation">Choy E., Yelensky R., Bonakdar S., Plenge R. M., Saxena R., De Jager P. L., et al. (2008). <span class="ref-title">Genetic analysis of human traits <em>in vitro</em>: drug response and gene expression in lymphoblastoid cell lines</span>. <span class="ref-journal">PLoS Genet</span>. <span class="ref-vol">4</span>:e1000287
 10.1371/journal.pgen.1000287 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2583954/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19043577" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pgen.1000287" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Genetic+analysis+of+human+traits+in+vitro:+drug+response+and+gene+expression+in+lymphoblastoid+cell+lines&amp;author=E.+Choy&amp;author=R.+Yelensky&amp;author=S.+Bonakdar&amp;author=R.+M.+Plenge&amp;author=R.+Saxena&amp;volume=4&amp;publication_year=2008&amp;pages=e1000287&amp;pmid=19043577&amp;doi=10.1371/journal.pgen.1000287&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B10"><span class="mixed-citation">Ciafre S. A., Galardi S., Mangiola A., Ferracin M., Liu C. G., Sabatino G., et al. (2005). <span class="ref-title">Extensive modulation of a set of microRNAs in primary glioblastoma</span>. <span class="ref-journal">Biochem. Biophys. Res. Commun</span>. <span class="ref-vol">334</span>, 1351&#x02013;1358
 10.1016/j.bbrc.2005.07.030 [<a href="https://pubmed.ncbi.nlm.nih.gov/16039986" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bbrc.2005.07.030" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.+Biophys.+Res.+Commun&amp;title=Extensive+modulation+of+a+set+of+microRNAs+in+primary+glioblastoma&amp;author=S.+A.+Ciafre&amp;author=S.+Galardi&amp;author=A.+Mangiola&amp;author=M.+Ferracin&amp;author=C.+G.+Liu&amp;volume=334&amp;publication_year=2005&amp;pages=1351-1358&amp;pmid=16039986&amp;doi=10.1016/j.bbrc.2005.07.030&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B11"><span class="mixed-citation">Cloughesy T. F., Yoshimoto K., Nghiemphu P., Brown K., Dang J., Zhu S., et al. (2008). <span class="ref-title">Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-deficient glioblastoma</span>. <span class="ref-journal">PLoS Med</span>. <span class="ref-vol">5</span>:e8
 10.1371/journal.pmed.0050008 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2211560/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18215105" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pmed.0050008" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Med&amp;title=Antitumor+activity+of+rapamycin+in+a+phase+I+trial+for+patients+with+recurrent+PTEN-deficient+glioblastoma&amp;author=T.+F.+Cloughesy&amp;author=K.+Yoshimoto&amp;author=P.+Nghiemphu&amp;author=K.+Brown&amp;author=J.+Dang&amp;volume=5&amp;publication_year=2008&amp;pages=e8&amp;pmid=18215105&amp;doi=10.1371/journal.pmed.0050008&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B12"><span class="mixed-citation">Cunningham J. M., Oberg A. L., Borralho P. M., Kren B. T., French A. J., Wang L., et al. (2009). <span class="ref-title">Evaluation of a new high-dimensional miRNA profiling platform</span>. <span class="ref-journal">BMC Med. Genomics</span>
<span class="ref-vol">2</span>:57
 10.1186/1755-8794-2-57 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2744682/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19712457" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2F1755-8794-2-57" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Med.+Genomics&amp;title=Evaluation+of+a+new+high-dimensional+miRNA+profiling+platform&amp;author=J.+M.+Cunningham&amp;author=A.+L.+Oberg&amp;author=P.+M.+Borralho&amp;author=B.+T.+Kren&amp;author=A.+J.+French&amp;volume=2&amp;publication_year=2009&amp;pages=57&amp;pmid=19712457&amp;doi=10.1186/1755-8794-2-57&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B13"><span class="mixed-citation">Dimas A. S., Deutsch S., Stranger B. E., Montgomery S. B., Borel C., Attar-Cohen H., et al. (2009). <span class="ref-title">Common regulatory variation impacts gene expression in a cell type-dependent manner</span>. <span class="ref-journal">Science</span>
<span class="ref-vol">325</span>, 1246&#x02013;1250
 10.1126/science.1174148 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2867218/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19644074" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1126%2Fscience.1174148" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Common+regulatory+variation+impacts+gene+expression+in+a+cell+type-dependent+manner&amp;author=A.+S.+Dimas&amp;author=S.+Deutsch&amp;author=B.+E.+Stranger&amp;author=S.+B.+Montgomery&amp;author=C.+Borel&amp;volume=325&amp;publication_year=2009&amp;pages=1246-1250&amp;pmid=19644074&amp;doi=10.1126/science.1174148&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B14"><span class="mixed-citation">Eley G. D., Reiter J. L., Pandita A., Park S., Jenkins R. B., Maihle N. J., et al. (2002). <span class="ref-title">A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma</span>. <span class="ref-journal">Neuro. Oncol</span>. <span class="ref-vol">4</span>, 86&#x02013;94
 10.1093/neuonc/4.2.86 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1920657/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11916499" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fneuonc%2F4.2.86" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuro.+Oncol&amp;title=A+chromosomal+region+7p11.2+transcript+map:+its+development+and+application+to+the+study+of+EGFR+amplicons+in+glioblastoma&amp;author=G.+D.+Eley&amp;author=J.+L.+Reiter&amp;author=A.+Pandita&amp;author=S.+Park&amp;author=R.+B.+Jenkins&amp;volume=4&amp;publication_year=2002&amp;pages=86-94&amp;pmid=11916499&amp;doi=10.1093/neuonc/4.2.86&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B15"><span class="mixed-citation">Garzon R., Garofalo M., Martelli M. P., Briesewitz R., Wang L., Fernandez-Cymering C., et al. (2008). <span class="ref-title">Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin</span>. <span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A</span>. <span class="ref-vol">105</span>, 3945&#x02013;3950
 10.1073/pnas.0800135105 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2268779/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18308931" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.0800135105" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.S.A&amp;title=Distinctive+microRNA+signature+of+acute+myeloid+leukemia+bearing+cytoplasmic+mutated+nucleophosmin&amp;author=R.+Garzon&amp;author=M.+Garofalo&amp;author=M.+P.+Martelli&amp;author=R.+Briesewitz&amp;author=L.+Wang&amp;volume=105&amp;publication_year=2008&amp;pages=3945-3950&amp;pmid=18308931&amp;doi=10.1073/pnas.0800135105&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B16"><span class="mixed-citation">Garzon R., Pichiorri F., Palumbo T., Iuliano R., Cimmino A., Aqeilan R., et al. (2006). <span class="ref-title">MicroRNA fingerprints during human megakaryocytopoiesis</span>. <span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A</span>. <span class="ref-vol">103</span>, 5078&#x02013;5083
 10.1073/pnas.0600587103 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1458797/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16549775" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.0600587103" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.S.A&amp;title=MicroRNA+fingerprints+during+human+megakaryocytopoiesis&amp;author=R.+Garzon&amp;author=F.+Pichiorri&amp;author=T.+Palumbo&amp;author=R.+Iuliano&amp;author=A.+Cimmino&amp;volume=103&amp;publication_year=2006&amp;pages=5078-5083&amp;pmid=16549775&amp;doi=10.1073/pnas.0600587103&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B17"><span class="mixed-citation">Gaur A., Jewell D. A., Liang Y., Ridzon D., Moore J. H., Chen C., et al. (2007). <span class="ref-title">Characterization of microRNA expression levels and their biological correlates in human cancer cell lines</span>. <span class="ref-journal">Cancer Res</span>. <span class="ref-vol">67</span>, 2456&#x02013;2468
 10.1158/0008-5472.CAN-06-2698 [<a href="https://pubmed.ncbi.nlm.nih.gov/17363563" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-06-2698" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Characterization+of+microRNA+expression+levels+and+their+biological+correlates+in+human+cancer+cell+lines&amp;author=A.+Gaur&amp;author=D.+A.+Jewell&amp;author=Y.+Liang&amp;author=D.+Ridzon&amp;author=J.+H.+Moore&amp;volume=67&amp;publication_year=2007&amp;pages=2456-2468&amp;pmid=17363563&amp;doi=10.1158/0008-5472.CAN-06-2698&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B18"><span class="mixed-citation">Guertin D. A., Sabatini D. M. (2005). <span class="ref-title">An expanding role for mTOR in cancer</span>. <span class="ref-journal">Trends Mol. Med</span>. <span class="ref-vol">11</span>, 353&#x02013;361
 10.1016/j.molmed.2005.06.007 [<a href="https://pubmed.ncbi.nlm.nih.gov/16002336" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.molmed.2005.06.007" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Mol.+Med&amp;title=An+expanding+role+for+mTOR+in+cancer&amp;author=D.+A.+Guertin&amp;author=D.+M.+Sabatini&amp;volume=11&amp;publication_year=2005&amp;pages=353-361&amp;pmid=16002336&amp;doi=10.1016/j.molmed.2005.06.007&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B19"><span class="mixed-citation">Han L., Witmer P. D., Casey E., Valle D., Sukumar S. (2007). <span class="ref-title">DNA methylation regulates MicroRNA expression</span>. <span class="ref-journal">Cancer Biol. Ther</span>. <span class="ref-vol">6</span>, 1284&#x02013;1288
 10.4161/cbt.6.8.4486 [<a href="https://pubmed.ncbi.nlm.nih.gov/17660710" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.4161%2Fcbt.6.8.4486" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Biol.+Ther&amp;title=DNA+methylation+regulates+MicroRNA+expression&amp;author=L.+Han&amp;author=P.+D.+Witmer&amp;author=E.+Casey&amp;author=D.+Valle&amp;author=S.+Sukumar&amp;volume=6&amp;publication_year=2007&amp;pages=1284-1288&amp;pmid=17660710&amp;doi=10.4161/cbt.6.8.4486&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B20"><span class="mixed-citation">Hartford C. M., Ratain M. J. (2007). <span class="ref-title">Rapamycin: something old, something new, sometimes borrowed and now renewed</span>. <span class="ref-journal">Clin. Pharmacol. Ther</span>. <span class="ref-vol">82</span>, 381&#x02013;388
 10.1038/sj.clpt.6100317 [<a href="https://pubmed.ncbi.nlm.nih.gov/17728765" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsj.clpt.6100317" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Pharmacol.+Ther&amp;title=Rapamycin:+something+old,+something+new,+sometimes+borrowed+and+now+renewed&amp;author=C.+M.+Hartford&amp;author=M.+J.+Ratain&amp;volume=82&amp;publication_year=2007&amp;pages=381-388&amp;pmid=17728765&amp;doi=10.1038/sj.clpt.6100317&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B21"><span class="mixed-citation">Ingle J. N., Schaid D. J., Goss P. E., Liu M., Mushiroda T., Chapman J. A., et al. (2010). <span class="ref-title">Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors</span>. <span class="ref-journal">J. Clin. Oncol</span>. <span class="ref-vol">28</span>, 4674&#x02013;4682
 10.1200/JCO.2010.28.5064 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3020700/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20876420" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1200%2FJCO.2010.28.5064" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Clin.+Oncol&amp;title=Genome-wide+associations+and+functional+genomic+studies+of+musculoskeletal+adverse+events+in+women+receiving+aromatase+inhibitors&amp;author=J.+N.+Ingle&amp;author=D.+J.+Schaid&amp;author=P.+E.+Goss&amp;author=M.+Liu&amp;author=T.+Mushiroda&amp;volume=28&amp;publication_year=2010&amp;pages=4674-4682&amp;pmid=20876420&amp;doi=10.1200/JCO.2010.28.5064&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B22"><span class="mixed-citation">Inoki K., Corradetti M. N., Guan K. L. (2005). <span class="ref-title">Dysregulation of the TSC-mTOR pathway in human disease</span>. <span class="ref-journal">Nat. Genet</span>. <span class="ref-vol">37</span>, 19&#x02013;24
 10.1038/ng1494 [<a href="https://pubmed.ncbi.nlm.nih.gov/15624019" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fng1494" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Genet&amp;title=Dysregulation+of+the+TSC-mTOR+pathway+in+human+disease&amp;author=K.+Inoki&amp;author=M.+N.+Corradetti&amp;author=K.+L.+Guan&amp;volume=37&amp;publication_year=2005&amp;pages=19-24&amp;pmid=15624019&amp;doi=10.1038/ng1494&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B23"><span class="mixed-citation">Jacinto E., Hall M. N. (2003). <span class="ref-title">Tor signalling in bugs, brain and brawn</span>. <span class="ref-journal">Nat. Rev. Mol. Cell Biol</span>. <span class="ref-vol">4</span>, 117&#x02013;126
 10.1038/nrm1018 [<a href="https://pubmed.ncbi.nlm.nih.gov/12563289" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnrm1018" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Mol.+Cell+Biol&amp;title=Tor+signalling+in+bugs,+brain+and+brawn&amp;author=E.+Jacinto&amp;author=M.+N.+Hall&amp;volume=4&amp;publication_year=2003&amp;pages=117-126&amp;pmid=12563289&amp;doi=10.1038/nrm1018&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B24"><span class="mixed-citation">Jongen-Lavrencic M., Sun S. M., Dijkstra M. K., Valk P. J., Lowenberg B. (2008). <span class="ref-title">MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia</span>. <span class="ref-journal">Blood</span>
<span class="ref-vol">111</span>, 5078&#x02013;5085
 10.1182/blood-2008-01-133355 [<a href="https://pubmed.ncbi.nlm.nih.gov/18337557" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1182%2Fblood-2008-01-133355" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=MicroRNA+expression+profiling+in+relation+to+the+genetic+heterogeneity+of+acute+myeloid+leukemia&amp;author=M.+Jongen-Lavrencic&amp;author=S.+M.+Sun&amp;author=M.+K.+Dijkstra&amp;author=P.+J.+Valk&amp;author=B.+Lowenberg&amp;volume=111&amp;publication_year=2008&amp;pages=5078-5085&amp;pmid=18337557&amp;doi=10.1182/blood-2008-01-133355&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B25"><span class="mixed-citation">Kim B. C., Ryu M. S., Oh S. P., Lim I. K. (2008). <span class="ref-title">TIS21/(BTG2) negatively regulates estradiol-stimulated expansion of hematopoietic stem cells by derepressing Akt phosphorylation and inhibiting mTOR signal transduction</span>. <span class="ref-journal">Stem Cells</span>
<span class="ref-vol">26</span>, 2339&#x02013;2348
 10.1634/stemcells.2008-0327 [<a href="https://pubmed.ncbi.nlm.nih.gov/18556508" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1634%2Fstemcells.2008-0327" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Stem+Cells&amp;title=TIS21/(BTG2)+negatively+regulates+estradiol-stimulated+expansion+of+hematopoietic+stem+cells+by+derepressing+Akt+phosphorylation+and+inhibiting+mTOR+signal+transduction&amp;author=B.+C.+Kim&amp;author=M.+S.+Ryu&amp;author=S.+P.+Oh&amp;author=I.+K.+Lim&amp;volume=26&amp;publication_year=2008&amp;pages=2339-2348&amp;pmid=18556508&amp;doi=10.1634/stemcells.2008-0327&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B26"><span class="mixed-citation">Le Meur Y., Djebli N., Szelag J. C., Hoizey G., Toupance O., Rerolle J. P., et al. (2006). <span class="ref-title">CYP3A5<sup>*</sup>3 influences sirolimus oral clearance in de novo and stable renal transplant recipients</span>. <span class="ref-journal">Clin. Pharmacol. Ther</span>. <span class="ref-vol">80</span>, 51&#x02013;60
 10.1016/j.clpt.2006.03.012 [<a href="https://pubmed.ncbi.nlm.nih.gov/16815317" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.clpt.2006.03.012" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Pharmacol.+Ther&amp;title=CYP3A5*3+influences+sirolimus+oral+clearance+in+de+novo+and+stable+renal+transplant+recipients&amp;author=Y.+Le+Meur&amp;author=N.+Djebli&amp;author=J.+C.+Szelag&amp;author=G.+Hoizey&amp;author=O.+Toupance&amp;volume=80&amp;publication_year=2006&amp;pages=51-60&amp;pmid=16815317&amp;doi=10.1016/j.clpt.2006.03.012&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B27"><span class="mixed-citation">Li L., Fridley B., Kalari K., Jenkins G., Batzler A., Safgren S., et al. (2008). <span class="ref-title">Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression</span>. <span class="ref-journal">Cancer Res</span>. <span class="ref-vol">68</span>, 7050&#x02013;7058
 10.1158/0008-5472.CAN-08-0405 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2562356/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18757419" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-08-0405" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Gemcitabine+and+cytosine+arabinoside+cytotoxicity:+association+with+lymphoblastoid+cell+expression&amp;author=L.+Li&amp;author=B.+Fridley&amp;author=K.+Kalari&amp;author=G.+Jenkins&amp;author=A.+Batzler&amp;volume=68&amp;publication_year=2008&amp;pages=7050-7058&amp;pmid=18757419&amp;doi=10.1158/0008-5472.CAN-08-0405&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B28"><span class="mixed-citation">Li L., Fridley B. L., Kalari K., Jenkins G., Batzler A., Weinshilboum R. M., et al. (2009). <span class="ref-title">Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers</span>. <span class="ref-journal">PLoS ONE</span>
<span class="ref-vol">4</span>:e7765
 10.1371/journal.pone.0007765 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2770319/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19898621" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pone.0007765" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Gemcitabine+and+arabinosylcytosin+pharmacogenomics:+genome-wide+association+and+drug+response+biomarkers&amp;author=L.+Li&amp;author=B.+L.+Fridley&amp;author=K.+Kalari&amp;author=G.+Jenkins&amp;author=A.+Batzler&amp;volume=4&amp;publication_year=2009&amp;pages=e7765&amp;pmid=19898621&amp;doi=10.1371/journal.pone.0007765&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B29"><span class="mixed-citation">Lund A. H. (2010). <span class="ref-title">miR-10 in development and cancer</span>. <span class="ref-journal">Cell Death Differ</span>. <span class="ref-vol">17</span>, 209&#x02013;214
 10.1038/cdd.2009.58 [<a href="https://pubmed.ncbi.nlm.nih.gov/19461655" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fcdd.2009.58" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Differ&amp;title=miR-10+in+development+and+cancer&amp;author=A.+H.+Lund&amp;volume=17&amp;publication_year=2010&amp;pages=209-214&amp;pmid=19461655&amp;doi=10.1038/cdd.2009.58&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B30"><span class="mixed-citation">Mansfield J. H., Harfe B. D., Nissen R., Obenauer J., Srineel J., Chaudhuri A., et al. (2004). <span class="ref-title">MicroRNA-responsive &#x02018;sensor&#x02019; transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression</span>. <span class="ref-journal">Nat. Genet</span>. <span class="ref-vol">36</span>, 1079&#x02013;1083
 10.1038/ng1421 [<a href="https://pubmed.ncbi.nlm.nih.gov/15361871" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fng1421" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Genet&amp;title=MicroRNA-responsive+&#x02018;sensor&#x02019;+transgenes+uncover+Hox-like+and+other+developmentally+regulated+patterns+of+vertebrate+microRNA+expression&amp;author=J.+H.+Mansfield&amp;author=B.+D.+Harfe&amp;author=R.+Nissen&amp;author=J.+Obenauer&amp;author=J.+Srineel&amp;volume=36&amp;publication_year=2004&amp;pages=1079-1083&amp;pmid=15361871&amp;doi=10.1038/ng1421&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B31"><span class="mixed-citation">Mao J. H., Kim I. J., Wu D., Climent J., Kang H. C., DelRosario R., et al. (2008). <span class="ref-title">FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression</span>. <span class="ref-journal">Science</span>
<span class="ref-vol">321</span>, 1499&#x02013;1502
 10.1126/science.1162981 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2849753/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18787170" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1126%2Fscience.1162981" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=FBXW7+targets+mTOR+for+degradation+and+cooperates+with+PTEN+in+tumor+suppression&amp;author=J.+H.+Mao&amp;author=I.+J.+Kim&amp;author=D.+Wu&amp;author=J.+Climent&amp;author=H.+C.+Kang&amp;volume=321&amp;publication_year=2008&amp;pages=1499-1502&amp;pmid=18787170&amp;doi=10.1126/science.1162981&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B32"><span class="mixed-citation">Meyuhas O. (2000). <span class="ref-title">Synthesis of the translational apparatus is regulated at the translational level</span>. <span class="ref-journal">Eur. J. Biochem</span>. <span class="ref-vol">267</span>, 6321&#x02013;6330
 10.1046/j.1432-1327.2000.01719.x [<a href="https://pubmed.ncbi.nlm.nih.gov/11029573" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1046%2Fj.1432-1327.2000.01719.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+J.+Biochem&amp;title=Synthesis+of+the+translational+apparatus+is+regulated+at+the+translational+level&amp;author=O.+Meyuhas&amp;volume=267&amp;publication_year=2000&amp;pages=6321-6330&amp;pmid=11029573&amp;doi=10.1046/j.1432-1327.2000.01719.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B33"><span class="mixed-citation">Miao L. Y., Huang C. R., Hou J. Q., Qian M. Y. (2008). <span class="ref-title">Association study of ABCB1 and CYP3A5 gene polymorphisms with sirolimus trough concentration and dose requirements in Chinese renal transplant recipients</span>. <span class="ref-journal">Biopharm. Drug Dispos</span>. <span class="ref-vol">29</span>, 1&#x02013;5
 10.1002/bdd.577 [<a href="https://pubmed.ncbi.nlm.nih.gov/17941052" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fbdd.577" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biopharm.+Drug+Dispos&amp;title=Association+study+of+ABCB1+and+CYP3A5+gene+polymorphisms+with+sirolimus+trough+concentration+and+dose+requirements+in+Chinese+renal+transplant+recipients&amp;author=L.+Y.+Miao&amp;author=C.+R.+Huang&amp;author=J.+Q.+Hou&amp;author=M.+Y.+Qian&amp;volume=29&amp;publication_year=2008&amp;pages=1-5&amp;pmid=17941052&amp;doi=10.1002/bdd.577&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B34"><span class="mixed-citation">Mourad M., Mourad G., Wallemacq P., Garrigue V., Van Bellingen C., Van Kerckhove V., et al. (2005). <span class="ref-title">Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids</span>. <span class="ref-journal">Transplantation</span>
<span class="ref-vol">80</span>, 977&#x02013;984
 10.1097/01.TP.0000174131.47469.D2 [<a href="https://pubmed.ncbi.nlm.nih.gov/16249748" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1097%2F01.TP.0000174131.47469.D2" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Transplantation&amp;title=Sirolimus+and+tacrolimus+trough+concentrations+and+dose+requirements+after+kidney+transplantation+in+relation+to+CYP3A5+and+MDR1+polymorphisms+and+steroids&amp;author=M.+Mourad&amp;author=G.+Mourad&amp;author=P.+Wallemacq&amp;author=V.+Garrigue&amp;author=C.+Van+Bellingen&amp;volume=80&amp;publication_year=2005&amp;pages=977-984&amp;pmid=16249748&amp;doi=10.1097/01.TP.0000174131.47469.D2&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B35"><span class="mixed-citation">Nagaraja A. K., Creighton C. J., Yu Z., Zhu H., Gunaratne P. H., Reid J. G., et al. (2010). <span class="ref-title">A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer</span>. <span class="ref-journal">Mol. Endocrinol</span>. <span class="ref-vol">24</span>, 447&#x02013;463
 10.1210/me.2009-0295 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2817607/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20081105" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fme.2009-0295" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Endocrinol&amp;title=A+link+between+mir-100+and+FRAP1/mTOR+in+clear+cell+ovarian+cancer&amp;author=A.+K.+Nagaraja&amp;author=C.+J.+Creighton&amp;author=Z.+Yu&amp;author=H.+Zhu&amp;author=P.+H.+Gunaratne&amp;volume=24&amp;publication_year=2010&amp;pages=447-463&amp;pmid=20081105&amp;doi=10.1210/me.2009-0295&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B36"><span class="mixed-citation">Niu N., Qin Y., Fridley B. L., Hou J., Kalari K. R., Zhu M., et al. (2010). <span class="ref-title">Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines</span>. <span class="ref-journal">Genome Res</span>. <span class="ref-vol">20</span>, 1482&#x02013;1492
 10.1101/gr.107672.110 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2963812/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20923822" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1101%2Fgr.107672.110" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Res&amp;title=Radiation+pharmacogenomics:+a+genome-wide+association+approach+to+identify+radiation+response+biomarkers+using+human+lymphoblastoid+cell+lines&amp;author=N.+Niu&amp;author=Y.+Qin&amp;author=B.+L.+Fridley&amp;author=J.+Hou&amp;author=K.+R.+Kalari&amp;volume=20&amp;publication_year=2010&amp;pages=1482-1492&amp;pmid=20923822&amp;doi=10.1101/gr.107672.110&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B37"><span class="mixed-citation">Oneyama C., Ikeda J., Okuzaki D., Suzuki K., Kanou T., Shintani Y., et al. (2011). <span class="ref-title">MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways</span>. <span class="ref-journal">Oncogene</span>
<span class="ref-vol">30</span>, 3489&#x02013;3501
 10.1038/onc.2011.63 [<a href="https://pubmed.ncbi.nlm.nih.gov/21383697" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fonc.2011.63" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=MicroRNA-mediated+downregulation+of+mTOR/FGFR3+controls+tumor+growth+induced+by+Src-related+oncogenic+pathways&amp;author=C.+Oneyama&amp;author=J.+Ikeda&amp;author=D.+Okuzaki&amp;author=K.+Suzuki&amp;author=T.+Kanou&amp;volume=30&amp;publication_year=2011&amp;pages=3489-3501&amp;pmid=21383697&amp;doi=10.1038/onc.2011.63&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B38"><span class="mixed-citation">Pantuck A. J., Thomas G., Belldegrun A. S., Figlin R. A. (2006). <span class="ref-title">Mammalian target of rapamycin inhibitors in renal cell carcinoma: current status and future applications</span>. <span class="ref-journal">Semin. Oncol</span>. <span class="ref-vol">33</span>, 607&#x02013;613
 10.1053/j.seminoncol.2006.06.002 [<a href="https://pubmed.ncbi.nlm.nih.gov/17045090" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1053%2Fj.seminoncol.2006.06.002" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin.+Oncol&amp;title=Mammalian+target+of+rapamycin+inhibitors+in+renal+cell+carcinoma:+current+status+and+future+applications&amp;author=A.+J.+Pantuck&amp;author=G.+Thomas&amp;author=A.+S.+Belldegrun&amp;author=R.+A.+Figlin&amp;volume=33&amp;publication_year=2006&amp;pages=607-613&amp;pmid=17045090&amp;doi=10.1053/j.seminoncol.2006.06.002&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B39"><span class="mixed-citation">Park S., James C. D. (2005). <span class="ref-title">ECop (EGFR-Coamplified and overexpressed protein), a novel protein, regulates NF-[kappa]B transcriptional activity and associated apoptotic response in an I[kappa]B[alpha]-dependent manner</span>. <span class="ref-journal">Oncogene</span>
<span class="ref-vol">24</span>, 2495&#x02013;2502
 10.1038/sj.onc.1208496 [<a href="https://pubmed.ncbi.nlm.nih.gov/15735698" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsj.onc.1208496" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=ECop+(EGFR-Coamplified+and+overexpressed+protein),+a+novel+protein,+regulates+NF-[kappa]B+transcriptional+activity+and+associated+apoptotic+response+in+an+I[kappa]B[alpha]-dependent+manner&amp;author=S.+Park&amp;author=C.+D.+James&amp;volume=24&amp;publication_year=2005&amp;pages=2495-2502&amp;pmid=15735698&amp;doi=10.1038/sj.onc.1208496&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B40"><span class="mixed-citation">Pei H., Li L., Fridley B. L., Jenkins G. D., Kalari K. R., Lingle W., et al. (2009). <span class="ref-title">FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt</span>. <span class="ref-journal">Cancer Cell</span>
<span class="ref-vol">16</span>, 259&#x02013;266
 10.1016/j.ccr.2009.07.016 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2755578/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19732725" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ccr.2009.07.016" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Cell&amp;title=FKBP51+affects+cancer+cell+response+to+chemotherapy+by+negatively+regulating+Akt&amp;author=H.+Pei&amp;author=L.+Li&amp;author=B.+L.+Fridley&amp;author=G.+D.+Jenkins&amp;author=K.+R.+Kalari&amp;volume=16&amp;publication_year=2009&amp;pages=259-266&amp;pmid=19732725&amp;doi=10.1016/j.ccr.2009.07.016&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B41"><span class="mixed-citation">Petroulakis E., Mamane Y., Le Bacquer O., Shahbazian D., Sonenberg N. (2006). <span class="ref-title">mTOR signaling: implications for cancer and anticancer therapy</span>. <span class="ref-journal">Br. J. Cancer</span>
<span class="ref-vol">94</span>, 195&#x02013;199
 10.1038/sj.bjc.6602902 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2361102/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16404421" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsj.bjc.6602902" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br.+J.+Cancer&amp;title=mTOR+signaling:+implications+for+cancer+and+anticancer+therapy&amp;author=E.+Petroulakis&amp;author=Y.+Mamane&amp;author=O.+Le+Bacquer&amp;author=D.+Shahbazian&amp;author=N.+Sonenberg&amp;volume=94&amp;publication_year=2006&amp;pages=195-199&amp;pmid=16404421&amp;doi=10.1038/sj.bjc.6602902&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B42"><span class="mixed-citation">Price A. L., Patterson N. J., Plenge R. M., Weinblatt M. E., Shadick N. A., Reich D. (2006). <span class="ref-title">Principal components analysis corrects for stratification in genome-wide association studies</span>. <span class="ref-journal">Nat. Genet</span>. <span class="ref-vol">38</span>, 904&#x02013;909
 10.1038/ng1847 [<a href="https://pubmed.ncbi.nlm.nih.gov/16862161" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fng1847" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Genet&amp;title=Principal+components+analysis+corrects+for+stratification+in+genome-wide+association+studies&amp;author=A.+L.+Price&amp;author=N.+J.+Patterson&amp;author=R.+M.+Plenge&amp;author=M.+E.+Weinblatt&amp;author=N.+A.+Shadick&amp;volume=38&amp;publication_year=2006&amp;pages=904-909&amp;pmid=16862161&amp;doi=10.1038/ng1847&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B43"><span class="mixed-citation">Renders L., Frisman M., Ufer M., Mosyagin I., Haenisch S., Ott U., et al. (2007). <span class="ref-title">CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients</span>. <span class="ref-journal">Clin. Pharmacol. Ther</span>. <span class="ref-vol">81</span>, 228&#x02013;234
 10.1038/sj.clpt.6100039 [<a href="https://pubmed.ncbi.nlm.nih.gov/17192769" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsj.clpt.6100039" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Pharmacol.+Ther&amp;title=CYP3A5+genotype+markedly+influences+the+pharmacokinetics+of+tacrolimus+and+sirolimus+in+kidney+transplant+recipients&amp;author=L.+Renders&amp;author=M.+Frisman&amp;author=M.+Ufer&amp;author=I.+Mosyagin&amp;author=S.+Haenisch&amp;volume=81&amp;publication_year=2007&amp;pages=228-234&amp;pmid=17192769&amp;doi=10.1038/sj.clpt.6100039&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B44"><span class="mixed-citation">Richter J. D., Sonenberg N. (2005). <span class="ref-title">Regulation of cap-dependent translation by eIF4E inhibitory proteins</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">433</span>, 477&#x02013;480
 10.1038/nature03205 [<a href="https://pubmed.ncbi.nlm.nih.gov/15690031" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnature03205" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Regulation+of+cap-dependent+translation+by+eIF4E+inhibitory+proteins&amp;author=J.+D.+Richter&amp;author=N.+Sonenberg&amp;volume=433&amp;publication_year=2005&amp;pages=477-480&amp;pmid=15690031&amp;doi=10.1038/nature03205&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B45"><span class="mixed-citation">Rowinsky E. K. (2004). <span class="ref-title">Targeting the molecular target of rapamycin (mTOR)</span>. <span class="ref-journal">Curr. Opin. Oncol</span>. <span class="ref-vol">16</span>, 564&#x02013;575
 10.1097/01.cco.0000143964.74936.d1 [<a href="https://pubmed.ncbi.nlm.nih.gov/15627018" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1097%2F01.cco.0000143964.74936.d1" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr.+Opin.+Oncol&amp;title=Targeting+the+molecular+target+of+rapamycin+(mTOR)&amp;author=E.+K.+Rowinsky&amp;volume=16&amp;publication_year=2004&amp;pages=564-575&amp;pmid=15627018&amp;doi=10.1097/01.cco.0000143964.74936.d1&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B46"><span class="mixed-citation">Shenouda S. K., Alahari S. K. (2009). <span class="ref-title">MicroRNA function in cancer: oncogene or a tumor suppressor?</span>
<span class="ref-journal">Cancer Metastasis Rev</span>. <span class="ref-vol">28</span>, 369&#x02013;378
 10.1007/s10555-009-9188-5 [<a href="https://pubmed.ncbi.nlm.nih.gov/20012925" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs10555-009-9188-5" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Metastasis+Rev&amp;title=MicroRNA+function+in+cancer:+oncogene+or+a+tumor+suppressor?&amp;author=S.+K.+Shenouda&amp;author=S.+K.+Alahari&amp;volume=28&amp;publication_year=2009&amp;pages=369-378&amp;pmid=20012925&amp;doi=10.1007/s10555-009-9188-5&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B47"><span class="mixed-citation">Sie L., Loong S., Tan E. K. (2009). <span class="ref-title">Utility of lymphoblastoid cell lines</span>. <span class="ref-journal">J. Neurosci. Res</span>. <span class="ref-vol">87</span>, 1953&#x02013;1959
 10.1002/jnr.22000 [<a href="https://pubmed.ncbi.nlm.nih.gov/19224581" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fjnr.22000" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Neurosci.+Res&amp;title=Utility+of+lymphoblastoid+cell+lines&amp;author=L.+Sie&amp;author=S.+Loong&amp;author=E.+K.+Tan&amp;volume=87&amp;publication_year=2009&amp;pages=1953-1959&amp;pmid=19224581&amp;doi=10.1002/jnr.22000&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B48"><span class="mixed-citation">Storey J. D. (2002). <span class="ref-title">A direct approach to false discovery rates</span>. <span class="ref-journal">J. Royal Stat. Soc. B</span>
<span class="ref-vol">64</span>, 479&#x02013;498
 10.1111/1467-9868.00346 [<a href="//doi.org/10.1111%2F1467-9868.00346" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Royal+Stat.+Soc.+B&amp;title=A+direct+approach+to+false+discovery+rates&amp;author=J.+D.+Storey&amp;volume=64&amp;publication_year=2002&amp;pages=479-498&amp;doi=10.1111/1467-9868.00346&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B49"><span class="mixed-citation">Storey J. D. (2003). <span class="ref-title">The positive false discovery rate: a bayesian interpretation and the q-value</span>. <span class="ref-journal">Ann. Stat</span>. <span class="ref-vol">31</span>, 2013&#x02013;2015
 10.1214/aos/1074290335 [<a href="//doi.org/10.1214%2Faos%2F1074290335" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann.+Stat&amp;title=The+positive+false+discovery+rate:+a+bayesian+interpretation+and+the+q-value&amp;author=J.+D.+Storey&amp;volume=31&amp;publication_year=2003&amp;pages=2013-2015&amp;doi=10.1214/aos/1074290335&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B50"><span class="mixed-citation">Sun Y., Ge Y., Drnevich J., Zhao Y., Band M., Chen J. (2010). <span class="ref-title">Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis</span>. <span class="ref-journal">J. Cell Biol</span>. <span class="ref-vol">189</span>, 1157&#x02013;1169
 10.1083/jcb.200912093 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2894448/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20566686" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1083%2Fjcb.200912093" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Cell+Biol&amp;title=Mammalian+target+of+rapamycin+regulates+miRNA-1+and+follistatin+in+skeletal+myogenesis&amp;author=Y.+Sun&amp;author=Y.+Ge&amp;author=J.+Drnevich&amp;author=Y.+Zhao&amp;author=M.+Band&amp;volume=189&amp;publication_year=2010&amp;pages=1157-1169&amp;pmid=20566686&amp;doi=10.1083/jcb.200912093&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B51"><span class="mixed-citation">Vignot S., Faivre S., Aguirre D., Raymond E. (2005). <span class="ref-title">mTOR-targeted therapy of cancer with rapamycin derivatives</span>. <span class="ref-journal">Ann. Oncol</span>. <span class="ref-vol">16</span>, 525&#x02013;537
 10.1093/annonc/mdi113 [<a href="https://pubmed.ncbi.nlm.nih.gov/15728109" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fannonc%2Fmdi113" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann.+Oncol&amp;title=mTOR-targeted+therapy+of+cancer+with+rapamycin+derivatives&amp;author=S.+Vignot&amp;author=S.+Faivre&amp;author=D.+Aguirre&amp;author=E.+Raymond&amp;volume=16&amp;publication_year=2005&amp;pages=525-537&amp;pmid=15728109&amp;doi=10.1093/annonc/mdi113&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B52"><span class="mixed-citation">Wang L., McLeod H. L., Weinshilboum R. M. (2011). <span class="ref-title">Genomics and drug response</span>. <span class="ref-journal">N. Engl. J. Med</span>. <span class="ref-vol">364</span>, 1144&#x02013;1153
 10.1056/NEJMra1010600 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3184612/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21428770" ref="reftype=pubmed&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1056%2FNEJMra1010600" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N.+Engl.+J.+Med&amp;title=Genomics+and+drug+response&amp;author=L.+Wang&amp;author=H.+L.+McLeod&amp;author=R.+M.+Weinshilboum&amp;volume=364&amp;publication_year=2011&amp;pages=1144-1153&amp;pmid=21428770&amp;doi=10.1056/NEJMra1010600&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B53"><span class="mixed-citation">Wu Z., Irizarry R. A., Gentleman R., Martinez-Murillo F., Spencer F. (2004). <span class="ref-title">A model-based background adjustment for oligonucleotide expression arrays</span>. <span class="ref-journal">J. Am. Stat. Assoc</span>. <span class="ref-vol">99</span>, 909&#x02013;917
 10.1198/016214504000000683 [<a href="//doi.org/10.1198%2F016214504000000683" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Am.+Stat.+Assoc&amp;title=A+model-based+background+adjustment+for+oligonucleotide+expression+arrays&amp;author=Z.+Wu&amp;author=R.+A.+Irizarry&amp;author=R.+Gentleman&amp;author=F.+Martinez-Murillo&amp;author=F.+Spencer&amp;volume=99&amp;publication_year=2004&amp;pages=909-917&amp;doi=10.1198/016214504000000683&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3757297&amp;issue-id=218515&amp;journal-id=1681&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li></ul></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Frontiers in Genetics</span> are provided here courtesy of <strong>Frontiers Media SA</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3757297/pdf/fgene-04-00166.pdf" class="int-view">PDF (2.6M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3757297/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3757297/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3757297" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3757297%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="lW7lrJt0vRLUMprWvjnAksxCPyJcUKAtOMHIMkqOc4qRUxEcyb2bYtp0lQJmGojn">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3757297%2F&amp;text=Genome-wide%20association%20study%20for%20biomarker%20identification%20of%20Rapamycin%20and%20Everolimus%20using%20a%20lymphoblastoid%20cell%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3757297%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757297/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3757297/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/24009623/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3757297/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/24009623/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3757297/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3757297/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC3757297/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
